M&A

Boehringer buys Abexxa, bolstering its immuno-oncology pipeline

Boehringer Ingelheim says it has agreed to buy US biotech Abexxa Biologics, its second acquisition in the cancer immunotherapy area in the space of a year. Texas-based Abexxa has been on the Boehringer’s radar since it was set up, as it provided seed funding for the preclinical-stage company in 2016, buying into its approach of …

Boehringer buys Abexxa, bolstering its immuno-oncology pipeline Read More »

Boehringer Ingelheim Acquires Abexxa to Expands its Immuno-oncology Research

Shots: The acquisition includes upfront, milestones, and other consideration payments. Abexxa will continue to operate in the Arlington The acquisition will allow Boehringer to access Abexxa’s expertise and capabilities in targeting cancer-specific proteins by using its technology to develop cancer immunotherapies and Abs for solid cancers The acquisition also bolsters Boehringer’s commitment to identifying the …

Boehringer Ingelheim Acquires Abexxa to Expands its Immuno-oncology Research Read More »

Walgreens Boots Alliance Invests $970B in Shields to ‘Further Expand Its Health Care Reach in Communities’

Walgreens Boots Alliance (Nasdaq: WBA) plans to invest $970 million in Shields Health Solutions, which aids both hospitals and health systems with specialty pharmacy services. It’s another major move for Walgreens, which is trying to position itself as an all-encompassing health care behemoth prepared for the sector’s near- and long-term trends. The deal, which is …

Walgreens Boots Alliance Invests $970B in Shields to ‘Further Expand Its Health Care Reach in Communities’ Read More »

Boston to Acquire Devoro for ~$336M

Shots: Boston currently holds ~16% equity stake in Devor & acquires the remaining 84% for ~$269M up front and ~$67M upon achievement of clinical & regulatory milestones. The transaction is expected to close in Q4’21 The acquisition will advance the peripheral interventions portfolio with the addition of Devoro’s WOLF thrombectomy platform to improve procedural efficiencies …

Boston to Acquire Devoro for ~$336M Read More »

Novartis to Acquire Arctos to Boost its Optogenetics Portfolio to Treat Eye Diseases

Shots: The acquisition expands Novartis’ ophthalmology portfolio with the addition of Arctos’ pre-clinical optogenetics-based AAV gene therapy program and its technology The acquisition marks the Novartis commitment to identify optogenetics-based therapies for the treatment of patients with vision loss Arctos has developed its technology to treat IRDs and other diseases that involve photoreceptor loss, such …

Novartis to Acquire Arctos to Boost its Optogenetics Portfolio to Treat Eye Diseases Read More »

Vectura investors ignore critics and back tobacco giant takeover

Tobacco giant Philip Morris International (PMI) has won the shareholder vote it needed for its controversial £1.1 billion takeover of respiratory drugmaker Vectura, despite mobilised opposition to the deal. PMI said it had won support from enough shareholders that – when added to its own holding in Vectura – it had a 75% position in …

Vectura investors ignore critics and back tobacco giant takeover Read More »

24 Hour Home Care Buys Non-Medical Division of Home Health ‘Bundling Expert’ GrandCare

Often in the home-based care field, transactions are driven by companies seeking to expand their service lines to become one-stop shops for referral partners. Sometimes, however, dealmaking is ignited by a desire to double down on existing expertise. An example of the latter M&A tactic happened Wednesday, with 24 Hour Home Care buying the non-medical …

24 Hour Home Care Buys Non-Medical Division of Home Health ‘Bundling Expert’ GrandCare Read More »

AbCellera Acquires TetraGenetics to Enhance its Capabilities for Developing Antibodies

Shots: AbCellera acquires TetraGenetics in an all-cash transaction that includes up front, milestones based on the achievement of technical milestones related to the development of therapeutics The acquisition will combine TetraGenetics’ capabilities with AbCellera’s technology to provides an optimized protein source for AbCellera’s Abs discovery across a range of therapeutic areas. The technology has the …

AbCellera Acquires TetraGenetics to Enhance its Capabilities for Developing Antibodies Read More »

Ginkgo Going Public with ~1.63B in Proceed Via Soaring Eagle SPAC Merger

Shots: The merger was approved in a shareholder vote with 75% participation & 97% in favor of the combination. Upon the closing of the merger, Ginkgo is eligible to receive ~1.63B in gross proceeds including $775M from a PIPE and ~$858M from the Soaring Eagle trust account Soaring Eagle will now change its name to …

Ginkgo Going Public with ~1.63B in Proceed Via Soaring Eagle SPAC Merger Read More »

AzurRx Signs a Reverse Triangular Merger Agreement to Acquire First Wave Bio for ~$229M

Shots: AzurRx to acquire First Wave Bio for $229M in cash & stock including development, regulatory & sales milestones. The transaction is anticipated to close imminently The acquisition will boost AzurRx’s GI pipeline including three new clinical IBD indications for UPS, UC & CD. In Jan’21, AzurRx in-licensed an exclusive global right to develop two …

AzurRx Signs a Reverse Triangular Merger Agreement to Acquire First Wave Bio for ~$229M Read More »

Transactions: The Pennant Group Buys Texas Hospice Provider; DispatchHealth Partners with Lee Health

The Pennant Group Inc. (Nasdaq: PNTG) has purchased the assets of Amarillo, Texas-based Open Heart Hospice. The financial terms of the deal were not disclosed. As part of the agreement, Open Heart Hospice will operate under the name Kinder Hearts Hospice of Amarillo. Sign up for HHCN + to read this exclusive content. Individual Membership …

Transactions: The Pennant Group Buys Texas Hospice Provider; DispatchHealth Partners with Lee Health Read More »

Roche to Acquire TIB Molbiol for Bolstering its Molecular Diagnostics Portfolio

Shots: Roche has signed a purchase agreement to acquire 100% of the outstanding shares of the TIB. The transaction is expected to close in Q4’21 The acquisition will bolster Roche’s PCR test portfolio of molecular diagnostics solutions with the addition of multiple assays for infectious disease TIB Molbiol currently has 45+ CE-IVD marked tests and …

Roche to Acquire TIB Molbiol for Bolstering its Molecular Diagnostics Portfolio Read More »

‘The Fittest Survive’: HHVBP Expansion Could Drive Home Health Consolidation

In the U.S. Centers for Medicare & Medicaid Services’ (CMS) proposed payment rule for 2022, the attention-grabber was the expansion of the Home Health Value-Based Purchasing (HHVBP) Model, the details of which excited some providers and left others concerned. While the specifics of the expansion plan were being discussed during the public comment period, however, …

‘The Fittest Survive’: HHVBP Expansion Could Drive Home Health Consolidation Read More »

ICU Medical Commits to Acquire Smith for ~$2.35B

Shots: Smiths to receive 2.5M at closing in cash and stock which is currently valued at ~$500M, $1.85B in cash along with liabilities & is eligible for up to $100M in milestones. The transaction is expected to close in H1’22 The acquisition combines Smiths’ business includes syringes, ambulatory infusion devices, vascular access & vital care …

ICU Medical Commits to Acquire Smith for ~$2.35B Read More »

LHC Group to Acquire Home Health Assets in 22 States from HCA-Brookdale Venture

LHC Group Inc. (Nasdaq: LHCG) has already hit a record year for M&A activity. It added to its streak in a major way on Wednesday, announcing an agreement to purchase Brookdale Health Care Services agencies in 22 states from the recently formed venture between Brookdale Senior Living Inc. (NYSE: BKD) and HCA Healthcare (NYSE: HCA). …

LHC Group to Acquire Home Health Assets in 22 States from HCA-Brookdale Venture Read More »

Sanofi snaps up Kadmon and its transplant drug Rezurock

Less than a month after Kadmon Pharma launched its first product – Rezurock for a complication of organ transplants – the New York company has agreed to be bought by Sanofi in a $1.9 billion deal. The merger agreement, which has been agreed by the boards of both companies, will see Sanofi pay $9.50 per …

Sanofi snaps up Kadmon and its transplant drug Rezurock Read More »

Hybrigenics says it wants a merger with Bone Therapeutics

French biopharma company Hybrigenics has made another bid to merge with Belgium’s Bone Therapeutics, a specialist in regenerative medicine that is still recovering from a setback in its lead development programme. Hybrigenics said in a press release today that it had started discussions with Bone Therapeutics, but the Belgian company was quick to come out …

Hybrigenics says it wants a merger with Bone Therapeutics Read More »

Transactions: Trive Capital Invests in Choice Health at Home; LHC Group Completes Heart of Hospice Deal

Trive Capital, a Dallas-based private equity firm, has formed a partnership with Choice Health at Home. Tyler, Texas-based Choice is a home health, hospice and rehabilitation services provider. The company operates in 40 total locations across Texas, Louisiana and Oklahoma, with over 800 licensed health care employees. Sign up for HHCN + to read this …

Transactions: Trive Capital Invests in Choice Health at Home; LHC Group Completes Heart of Hospice Deal Read More »

Abbott to Acquire Walk Vascular to Bolster its Peripheral Vascular Offerings

Shots: The acquisition will accelerate Abbott’s vascular portfolio with the addition of Walk Vascular’s peripheral thrombectomy systems to treat patients with peripheral blood clots Walk Vascular’s JETi & JETi AIO peripheral thrombectomy systems are aspiration systems for the removal of intravascular clots. The systems are supported by RWE, and Walk is currently enrolling ~250 patients …

Abbott to Acquire Walk Vascular to Bolster its Peripheral Vascular Offerings Read More »

Value-Based Care, PDGM Sparks Home Health Dealmaking Activity

The home health market has been a hotbed of M&A activity as of late, and there are a number of key factors sparking the dealmaking interest. Since its implementation in 2020, the Patient-Driven Groupings Model (PDGM) has loomed large in the home health space. Now, PDGM is a driving force behind much of the transaction …

Value-Based Care, PDGM Sparks Home Health Dealmaking Activity Read More »

Provider-Vendor Hybrid PathWell Acquires Caring Angels Home Health

The home health company PathWell began as a technology company aiming to help other operators with back-end issues. But when COVID-19 hit, it changed direction to become a provider itself, equipped with the capabilities it once exclusively sought to give to others. PathWell has now grown into a multi-state provider through expansion and acquisitions. And …

Provider-Vendor Hybrid PathWell Acquires Caring Angels Home Health Read More »

Baxter in Talks to Acquire Hill-Rom for ~$10B

Shots: Baxter in talks to acquire Hill-Rom for ~$10B with $150/ share representing a premium of 13% to the stock’s closing price of $132.90. The acquisition is expected to be announced later this week The decision follows an earlier bid in which Hill-Rom had turned down Baxter’s previous offer of $144/ share with a total …

Baxter in Talks to Acquire Hill-Rom for ~$10B Read More »

Digital mental health firms Headspace and Ginger in $3bn merger

A merger between two digital mental health companies – Headspace and Ginger – will create a $3 billion giant in a category that has been growing at breakneck speed as a result of the COVID-19 pandemic. The deal brings together Headspace’s meditation and mindfulness app – used by millions of people around the world – …

Digital mental health firms Headspace and Ginger in $3bn merger Read More »

#Healthin2Point00, Episode 229 | Headspace & Ginger merge, Connect America buys 100Plus

It’s M&A day here on Health in 2 Point 00! On Episode 229, Jess and I chat about the big news that Headspace and Ginger are merging to create Headspace Health (for more deets tune into Jess’s interview on WTF Health here). Next up, Connect America buys remote patient monitoring platform 100Plus. Finally, AllStripes raises …

#Healthin2Point00, Episode 229 | Headspace & Ginger merge, Connect America buys 100Plus Read More »

Pfizer vaults into CD47 arena, buying Trillium for $2.3 billion

Pfizer is the latest big pharma company to take a position on drugs that target CD47 – a ‘don’t eat me’ signal that protects cancer cells from being attacked by the immune system. The drugmaker has agreed a $2.3 billion deal to buy Canadian biotech Trillium Therapeutics and its two lead candidates – TTI-622 and …

Pfizer vaults into CD47 arena, buying Trillium for $2.3 billion Read More »

Pfizer to Acquire Trillium for ~$2.26B

Shorts: Pfizer will acquire all outstanding shares of Trillium for $18.50/share in cash making a total equity value of $2.26B with 203.8% premium on the stock’s last closing price The acquisition will bolster Pfizer’s R&D capabilities & accelerates clinical development of Trillium’s SIRPα fusion proteins i.e., TTI-622 & TTI-621 that are currently in P-Ib/II trial …

Pfizer to Acquire Trillium for ~$2.26B Read More »

Years after Pfizer merger, ex-Medivation exec gets insider trading charge

A Medivation executive at the heart of the company’s team that sold the company to Pfizer for $14 billion five years ago is facing allegations of insider trading. Matthew Panuwat A complaint filed by the US Securities and Exchange Commission (SEC) today accuses Matthew Panuwat, the then-head of business development at Medivation, of buying sizeable …

Years after Pfizer merger, ex-Medivation exec gets insider trading charge Read More »

Transactions: Alivia Care Acquires Better Life Home Health; Charter Health Care Group Buys Generations Hospice Care

Alivia’s new home health transaction Alivia Care Inc. has acquired Summerfield, Florida-based home health provider Better Life Home Health. Financial terms were not disclosed. Alivia Care is the parent company of Jacksonville, Florida-based Community Hospice & Palliative Care, which provides services for more than 1,200 patients across Florida. Sign up for HHCN + to read …

Transactions: Alivia Care Acquires Better Life Home Health; Charter Health Care Group Buys Generations Hospice Care Read More »

How to Avoid Home Health Dealmaking Landmines

Interest in acquisitions, mergers and joint venture arrangements continues to heat up in the home health space. But for every successful deal that’s closed, there’s another that ultimately ends up falling apart. While dealmaking landmines will always be present, smart home health providers can often work around trouble if they know where to step. Overall, …

How to Avoid Home Health Dealmaking Landmines Read More »

Aveanna Applauds 2022 Proposed Payment Rule, Sets Sights on Home Health Growth

In the wake of going public in the spring, the leadership team at Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) has been especially vocal about its appetite for major growth. The company’s leaders echoed this sentiment, highlighting a focus on home health in particular, during its Q2 2021 earnings call on Thursday. “Home health and hospice …

Aveanna Applauds 2022 Proposed Payment Rule, Sets Sights on Home Health Growth Read More »

Sharecare Acquires CareLinx from Generali in $65M Deal

Last year, CareLinx entered a new phase of its business with its entrance into the clinical side of home-based care. As a result, CareLinx saw major growth, which, in turn, made the company more attractive to prospective buyers. One of those interested parties has officially made a play for CareLinx. On Tuesday, Sharecare (Nasdaq: SHCR) …

Sharecare Acquires CareLinx from Generali in $65M Deal Read More »

The Pennant Group Holds Firm on Home Health Growth Strategy Amid Labor, COVID-19 Challenges

The Pennant Group Inc.’s (Nasdaq: PNTG) position is different from other, larger home health companies in the country, mainly in that a substantial portion of its overall revenue comes from senior living. COVID-19 is once again threatening senior care industries, making providers like Pennant more at risk for negative disruption. After all, lower occupancy in …

The Pennant Group Holds Firm on Home Health Growth Strategy Amid Labor, COVID-19 Challenges Read More »

Carlyle baulks at Vectura auction, but urges shareholders to back its bid

Private equity group Carlyle has said it won’t raise its offer for respiratory drug specialist Vectura to match a 165p per share offer from tobacco giant Philip Morris International (PMI). The investment firm said its 155p offer was “full and fair” and would not be raised, meaning that it would not enter into a head-to-head …

Carlyle baulks at Vectura auction, but urges shareholders to back its bid Read More »

Harmony Acquires ConSynance’s Asset for the Treatment of Narcolepsy and other Rare Neurological Diseases

Shots: Harmony to receive $3.5M up front & development and regulatory milestone along with royalties & will acquire full development and commercialization rights globally, Ex- Greater China The acquisition of HBS-102 marks a next-generation therapy after Wakix (pitolisant). Additionally, Harmony plans to build a robust portfolio to treat patients with rare neurological diseases & continue …

Harmony Acquires ConSynance’s Asset for the Treatment of Narcolepsy and other Rare Neurological Diseases Read More »

‘Significant, Transformational Changes’: Brookdale Hands Off Home Health Business

Brookdale Senior Living Inc. (NYSE: BKD) used to be one of the largest home health providers in the country, thanks to its health services segment. Moving forward, it won’t be. HCA Healthcare (NYSE: HCA) — one of the largest hospital systems in the U.S. — purchased 80% of that segment, with the deal official as …

‘Significant, Transformational Changes’: Brookdale Hands Off Home Health Business Read More »

ModivCare Wants Its Caregivers to Be the Home-Based Care Equivalent of ‘Air Traffic Controllers’

In the past year, ModivCare Inc. (Nasdaq: MODV) has hit the ground running in the home-based care space. With recent acquisitions, the company is further leaning into its goal of transforming from a transportation logistics company to a provider of holistic supportive care solutions designed to address social determinants of health.  Daniel Greenleaf, the president …

ModivCare Wants Its Caregivers to Be the Home-Based Care Equivalent of ‘Air Traffic Controllers’ Read More »

Bidding war breaks out for respiratory specialist Vectura

A flurry of new offers by Philip Morris International (PMI) and private equity firm Carlyle has hiked the value of respiratory medicines company Vectura to £1 more than a billion ($1.4 billion), with the tobacco giant leading the bidding at the latest count. Carlyle first broke ground with a 136 pence per share offer that …

Bidding war breaks out for respiratory specialist Vectura Read More »

Honor to Aquire Home Instead, Creating $2 Billion Home Care Services Company

Honor Technology, Inc. has acquired Home Instead, Inc., creating a $2 billion home care services company, the two announced Friday. The deal brings together the largest, highest-touch home care network and the leading home care technology and operations platform, according to the press release. “This is an incredibly exciting moment as we bring together the …

Honor to Aquire Home Instead, Creating $2 Billion Home Care Services Company Read More »

Medtronic to Acquire Intersect ENT for ~$1.1B

Shots: Medtronic to acquire all outstanding shares of Intersect ENT for $28.25/ share in cash, making a total deal value of ~$1.1B. The transaction is expected to be completed by H1’22 The acquisition will expand Medtronic’s product portfolio which is used in the ENT procedure. Additionally, the acquisition will add a bioabsorbable drug release platform …

Medtronic to Acquire Intersect ENT for ~$1.1B Read More »

Bayer to Acquire Vividion for ~$2B

Shots: Vividion to receive $1.5B up front & $500M milestone while Bayer to get full rights to Vividion’s discovery platform which consists of chemoproteomic screening technology, a data portal, and a chemistry library. The transaction is expected to close in Q3’21 The acquisition will strengthen Bayer’s drug discovery capabilities & expand it into new modalities. …

Bayer to Acquire Vividion for ~$2B Read More »

LHC Group Touts ‘Record Year’ for Acquired Revenue in 2021

Excluding 2018 — when it merged with Almost Family — LHC Group Inc. (Nasdaq: LHCG) has had its best year in terms of acquired revenue in its 27-year history during 2021, according to the company. Thanks to a string of home health and hospice deals, LHC Group has doubled its previous goal for acquired revenue …

LHC Group Touts ‘Record Year’ for Acquired Revenue in 2021 Read More »

Bayer bolsters R&D platform with $2bn Vividion takeover

Bayer headlined its second-quarter results this morning by unveiling a deal to buy Vividion Therapeutics, saying it will boost its ability to develop medicines against targets once considered “undruggable.” Bayer is paying $1.5 billion upfront to claim ownership of Vividion‘s drug discovery platform, which uses chemoproteomics to identify new binding sites on proteins and find …

Bayer bolsters R&D platform with $2bn Vividion takeover Read More »

Transactions: ModivCare to Buy VRI for $315M; Nova Leap Completes Home Care Deal

ModivCare expands into remote patient monitoring ModivCare Inc. (Nasdaq: MODV), a diversified health care services company with a large personal care business, has signed an agreement to acquire VRI Intermediate Holdings LLC, a provider of remote patient monitoring solutions. Under terms of the agreement, the Denver-based ModivCare will acquire 100% of VRI for a purchase …

Transactions: ModivCare to Buy VRI for $315M; Nova Leap Completes Home Care Deal Read More »

EvergreenHealth Home Care, Alivia Ready to Support Choose Home Legislation

Home-based care leaders are encouraged by the Choose Home Care Act of 2021’s introduction into the U.S. Senate — and what it could mean for the home health industry if it’s ultimately enacted. Brent Korte, Keith Myers and Susan Ponder-Stansel are among them. The trio spoke about the recently introduced legislation Monday at the National …

EvergreenHealth Home Care, Alivia Ready to Support Choose Home Legislation Read More »

Addus Doubles Credit Facility to $600M, Maintains Focus on Home Health Expansion

Addus HomeCare Corporation (Nasdaq: ADUS) has remained laser focused on one goal for some time now: building out all three of its home-based service lines in markets where it is already present. That requires a strategic and aggressive M&A strategy, which Addus has executed in the past year. It plans to continue making moves in …

Addus Doubles Credit Facility to $600M, Maintains Focus on Home Health Expansion Read More »

Sanofi swoops on partner Translate, buying the mRNA firm for $3.2bn

Sanofi has been forging ever-closer ties with its mRNA partner Translate Bio since the two started working together in 2018, and has now gone all in, offering $3.2 billion to buy the company outright. The $38-per-share deal – a 56% premium to Translate’s recent share price before an after-hours surge in the stock on rumours …

Sanofi swoops on partner Translate, buying the mRNA firm for $3.2bn Read More »

Sanofi to Acquire Translate Bio for ~$3.2B

Shots: Sanofi to acquire all outstanding shares of Translate Bio for $38.00/share in cash making a total equity value of ~$3.2B with a premium of 30.4% to Translate Bio’s one day prior closing price of $29.15. The acquisition is expected to complete in the Q3’21 The acquisition will utilize mRNA technology to further accelerates Sanofi’s …

Sanofi to Acquire Translate Bio for ~$3.2B Read More »

BD Acquires Tepha to Boost its Surgical Mesh Portfolio

Shots: The acquisition will utilize Tepha’s resorbable polymer technology to boost the growth of BD’s surgical mesh portfolio for the repair and regeneration of soft tissues The acquisition also provides strategic vertical integration for BD’s Phasix mesh products & includes Tepha’s GalaFLEX portfolio which is based on the novel P4HB polymer Additionally, an interventional segment …

BD Acquires Tepha to Boost its Surgical Mesh Portfolio Read More »

Humana Sets Stage for Kindred Takeover, Remains Hopeful About a 2022 Return to Normalcy

Despite still reeling from COVID-19-related headwinds, Humana Inc. (NYSE: HUM) experienced better-than-expected results in its home and provider businesses during the second quarter of 2021. “Our strong operating performance this year is, in part, attributed to our strong partnerships with providers who are delivering high-quality care to our members,” Bruce Broussard, president and CEO of …

Humana Sets Stage for Kindred Takeover, Remains Hopeful About a 2022 Return to Normalcy Read More »

Amgen to Acquire Teneobio for ~$2.5B

Shots: Amgen to acquire all outstanding shares of Teneobio for $900M as up front and $1.6B in cash as contingent milestones to Teneobio equity holders. The transaction is expected to be closed in H2’21 The acquisition will boost Amgen’s abilities to develop innovative therapies and expand its portfolio with the addition of early-stage oncology assets …

Amgen to Acquire Teneobio for ~$2.5B Read More »

ModivCare CEO on $340M CareFinders Deal: Our Goal Is to Build Out a National Platform

ModivCare Inc. (NYSE: MODV), the non-emergency medical transportation (NEMT) company that’s quickly becoming a major player in the home-based care space as well, announced Monday plans to buy CareFinders Total Care for $340 million. Once the deal is finalized, ModivCare will initially combine the CareFinders business with its existing personal care capabilities from Simplura Health …

ModivCare CEO on $340M CareFinders Deal: Our Goal Is to Build Out a National Platform Read More »

Aptar makes digital health play, agreeing deal to buy Voluntis

Drug delivery specialist Aptar Group has agreed a deal to take a near two-thirds share in Voluntis, a French developer of digital therapeutics (DTx), with a view to taking full control of the company later this year. Illinois-headquartered Apar – which makes inhalers, syringe components, eye drop bottles and other delivery systems for pharmaceuticals, cosmetics …

Aptar makes digital health play, agreeing deal to buy Voluntis Read More »

ModivCare to Acquire CareFinders Total Care in $340M Deal

Last September, ModivCare Inc. (NYSE: MODV) acquired the large personal care services provider Simplura Health Group for $575 million. Less than nine months later, ModivCare President and CEO ​​Daniel Greenleaf shared a vision for growing his company to a $1 billion home-based care player with a true national footprint. ModivCare has now taken a giant …

ModivCare to Acquire CareFinders Total Care in $340M Deal Read More »

PE-Backed Choice Completes 4th Acquisition of 2021, Buys Alpha Home Health and Hospice

Choice Health at Home has acquired Alpha Home Health and Hospice, further increasing the company’s Oklahoma footprint. Financial terms of the deal were not disclosed. Alpha provides home health and hospice services through five locations in Ada, Ardmore, Oklahoma City, Norman and Pauls Valley. Meanwhile, Tyler, Texas-based Choice is home health, hospice and rehabilitation services …

PE-Backed Choice Completes 4th Acquisition of 2021, Buys Alpha Home Health and Hospice Read More »

Help at Home Continues Executing on Growth Strategy, Acquires Community Care Systems

Help at Home — a private equity-backed provider of home- and community-based care — has acquired Community Care Systems (CCS). Financial terms of the transaction were not disclosed. Founded in the 1908s, the Illinois-based CCS will become part of the Help at Home network, adding 13 additional locations and nearly 6,000 new clients. With nearly …

Help at Home Continues Executing on Growth Strategy, Acquires Community Care Systems Read More »

Lexeo Acquires Stelios to Expands its Gene Therapy Pipeline for Rare Cardiovascular Diseases

Shots: Lexeo acquires exclusive rights to three preclinical AAV-mediated gene therapy programs for the treatment of rare cardiac disorders, focused on TNNI3-associated HCM & ARVC The acquisition will complement and bolster LEXEO’s advanced pre-clinical gene therapy pipeline with the addition of three novel programs for rare cardiac diseases Additionally, preclinical results from the TNNI3-associated HCM …

Lexeo Acquires Stelios to Expands its Gene Therapy Pipeline for Rare Cardiovascular Diseases Read More »

‘Friendly Home Care Competitors’ Family Tree and Evergreen Announce Merger

Two of the largest concierge-level caregiving, private nursing and care management firms in Houston, Texas, have merged. On Tuesday, Family Tree In-Home Care and Evergreen Private Care of Houston announced that the two companies have formally joined forces. The announcement echoes the increasing amount of consolidation happening in the home-based care space, as operators try …

‘Friendly Home Care Competitors’ Family Tree and Evergreen Announce Merger Read More »

Home Health Veterans Windley, Strange Hoping to Take Aveanna Above and Beyond $2 Billion

Rod Windley and Tony Strange have been in business with each other for decades. They continue to be partners today as the chairman and CEO, respectively, of Aveanna Healthcare (Nasdaq: AVAH). From The Healthfield Group Inc. and Gentiva Health Services, Kindred at Home’s predecessor, to Aveanna, Windley and Strange have helped build a handful of …

Home Health Veterans Windley, Strange Hoping to Take Aveanna Above and Beyond $2 Billion Read More »

After Closing Brookdale Deal, HCA Healthcare Continues to Show Home Health Potential

The day before it officially closed on its deal to acquire 80% of Brookdale Health Care Services (NYSE: BKD), HCA Healthcare (NYSE: HCA) finished a financial quarter that showed significant recovery for the behemoth hospital chain — and then some. As COVID-19 concerns waned for patients, admissions and revenue soared for HCA, which is set …

After Closing Brookdale Deal, HCA Healthcare Continues to Show Home Health Potential Read More »

BioNTech grows in cell therapies, buying Kite’s TCR platform

BioNTech has found a use for some of the windfall cash it has raked in from its COVID-19 vaccine, agreeing a deal to buy Kite Pharma’s entire neoantigen T cell receptor (TCR) platform for solid tumours, and an associated manufacturing plant. There’s no value attached to the deal – even though BioNTech is a publicly …

BioNTech grows in cell therapies, buying Kite’s TCR platform Read More »

Jet Health Lands Signal Home Health & Hospice in Ongoing Expansion Push

With its latest purchase of San Antonio, Texas-based Signal Home Health & Hospice, Jet Health continues its strategy of co-locating hospice operations with its home health offerings. That has become a calling card for the company, similar to several other home-based care providers. Jet Health announced the Signal deal on Monday without disclosing any financial …

Jet Health Lands Signal Home Health & Hospice in Ongoing Expansion Push Read More »

Transactions: Regence BlueShield Teams Up with DispatchHealth; Amedisys Enters New Market

Health insurer Regence BlueShield has partnered with DispatchHealth to give its members access to hospital-at-home and mobile high-acuity services. “Hospitalizations in the home is a groundbreaking and exciting shift in care delivery,” Dr. Drew Oliveira, senior executive medical director at Regence, said in a press release. “Our partnership with DispatchHealth enables Regence members to receive …

Transactions: Regence BlueShield Teams Up with DispatchHealth; Amedisys Enters New Market Read More »

Home Health Industry Must Prepare for Costs of Consolidation

At Home Health Care News, it seems like we’ve been writing about “the rapidly consolidating home health market” for years. Just check out this story from 2015, for example. There are also these more recent pieces from 2018 and 2019, respectively. In many ways, consolidation — either through agency closures or through M&A activity — …

Home Health Industry Must Prepare for Costs of Consolidation Read More »

Eli Lilly to Acquire Protomer Technologies for ~$1B

Shots: Eli Lilly to acquire Protomer Technologies for ~$1B, with the achievement of future development and commercial milestones Earlier, Lilly led an equity investment in Protomer along with JDRF T1D fund that provides Lilly with 14% ownership of promotor and is currently acquiring the remaining shares of Protomer beyond the initial investment The acquisition will …

Eli Lilly to Acquire Protomer Technologies for ~$1B Read More »

Mission Buys Healthy Living Network, Effectively Doubling Its Overall Business

Mission Healthcare announced Wednesday that it has acquired Healthy Living Network, a multi-state home health provider founded over a decade ago. The deal is the largest acquisition in the San Diego-based Mission’s history, CEO Paul VerHoeve told Home Health Care news. Additionally, by joining forces with Healthy Living Network, Mission effectively doubles its overall business …

Mission Buys Healthy Living Network, Effectively Doubling Its Overall Business Read More »

Lilly grabs glucose-sensing insulin tech, buying Protomer in $1bn deal

Eli Lilly bought a stake in Protomer Technologies and its glucose-sensing insulin platform last year, and it must like what it has seen in the programme since then – it has just agreed to buy the company outright.  Pasadena, California-based Protomer is working on proteins that can sense molecular activators in the body and only …

Lilly grabs glucose-sensing insulin tech, buying Protomer in $1bn deal Read More »

Final hurdle falls as UK backs AZ’s $39bn takeover of Alexion

The UK’s competition regulator has approved AstraZeneca’s $39 billion acquisition of US-based drugmaker Alexion, without opting for a broader inquiry into the deal. The nod from the Competition and Markets Authority (CMA) after an initial assessment means that it concluded no antitrust risks were associated with the deal. It was the final needed from a …

Final hurdle falls as UK backs AZ’s $39bn takeover of Alexion Read More »

Addus to Acquire Home Health, Hospice Provider Armada for $29M

Addus HomeCare Corporation (Nasdaq: ADUS) has signed a definitive agreement to acquire Armada Skilled Home Health and Hospice, further building out its already sizable footprint in the state of New Mexico. It’s yet another step for Addus in its quest to build out home health, hospice and personal care lines in specific markets and states, …

Addus to Acquire Home Health, Hospice Provider Armada for $29M Read More »

Novo Nordisk bulks up in rare diseases with $1.2bn Prothena deal

Diabetes giant Novo Nordisk has opened a new front in its rare disease R&D, thanks to an acquisition agreement with Prothena focusing on drugs for ATTR amyloidosis. The Danish drugmaker is paying $100 million upfront for rights to antibody drug PRX004, which is heading for phase 2 trials in cardiomyopathy associated with ATTR amyloidosis, a …

Novo Nordisk bulks up in rare diseases with $1.2bn Prothena deal Read More »

‘Home-Based Care Is Going to Become More Important’: VillageMD Continues Expanding U.S. Footprint

The past year has been a busy one for VillageMD. In 2020, Walgreens Boots Alliance (Nasdaq: WBA) entered into a partnership with the startup and announced that it would be investing $1 billion in the value-based primary care provider over the following three years. Since then, VillageMD — through its subsidiary Village Medical — has …

‘Home-Based Care Is Going to Become More Important’: VillageMD Continues Expanding U.S. Footprint Read More »

Transactions: Amedisys acquires VNA’s Home Health Assets; AccordCare Expands Medicaid Business

Amedisys Inc. (Nasdaq: AMED) has completed its purchase of Visiting Nurse Association’s (VNA) assets. Baton Rouge, Louisiana-based Amedisys has a number of in-home care capabilities, including home health, hospice and personal care services. Amedisys also recently acquired Contessa Health for $250 million. The deal gives the company a range of acute-level care services. Meanwhile, VNA …

Transactions: Amedisys acquires VNA’s Home Health Assets; AccordCare Expands Medicaid Business Read More »

Big tobacco’s PMI makes another pharma foray with Vectura deal

Tobacco giant Philip Morris International (PMI) has doubled down on its move into the pharmaceutical sector, following up its recent acquisition of Fertin Pharma with a deal to buy Vectura for around £1 billion ($1.38 billion). PMI is paying 150 pence per share for Vectura, trumping a 139 per share offer from private equity firm …

Big tobacco’s PMI makes another pharma foray with Vectura deal Read More »

Another hurdle down as EU clears AstraZeneca’s Alexion takeover

The European Commission has given competition clearance to the $39 billion acquisition of Alexion by AstraZeneca, leaving the UK as the last remaining obstacle to getting the deal across the line. The EU approval comes after the merger has already been okayed by the US, Japan and a number of other countries around the world, …

Another hurdle down as EU clears AstraZeneca’s Alexion takeover Read More »

Transactions: HCA Healthcare Completes $400M Deal with Brookdale; LHC Group Announces New Acquisitions

HCA Healthcare Inc. (NYSE:HCA) has completed its purchase of a majority stake in the home health and hospice business of Brookdale Senior Living Inc. (NYSE: BKD). Originally announced in February, the deal instantly turns HCA into one of the largest home health and hospice players in the country. “We view partnerships as foundational to our …

Transactions: HCA Healthcare Completes $400M Deal with Brookdale; LHC Group Announces New Acquisitions Read More »

Amedisys Looks to Pull Away from the Home Health Pack with ‘No Brainer’ Contessa Deal

Aging-in-place company Amedisys Inc. (Nasdaq: AMED) on Wednesday announced plans to acquire hospital-at-home pioneer Contessa Health for $250 million. From a nuts-and-bolts perspective, the deal — expected to close later this summer — makes a ton of sense for Amedisys. Among the strategic benefits, for example, it gives the Baton Rouge, Louisiana-based company an unprecedented …

Amedisys Looks to Pull Away from the Home Health Pack with ‘No Brainer’ Contessa Deal Read More »

[Updated] In ‘Strategic Milestone,’ Amedisys to Acquire Hospital-at-Home Company Contessa Health for $250M

Amedisys Inc. (Nasdaq: AMED) has an agreement in place to acquire Contessa Health, one of the biggest players in the hospital-at-home market, for $250 million. The acquisition takes Amedisys’ total addressable market for in-home care services from $44 billion to $73 billion, according to the company. Strategically, Amedisys believes it can leverage its existing home-based …

[Updated] In ‘Strategic Milestone,’ Amedisys to Acquire Hospital-at-Home Company Contessa Health for $250M Read More »

Encompass Health May Be Nearing Home Health, Hospice Spinoff

Encompass Health Corporation (NYSE: EHC) may be nearing a spinoff — not a sale — of its home health and hospice segment. That avenue looks increasingly likely in light of the company’s recent leadership announcements, industry insiders believe. Last week, Barb Jacobsmeyer was named the new CEO of Encompass Health’s home health and hospice segment, …

Encompass Health May Be Nearing Home Health, Hospice Spinoff Read More »

Arosa Acquires Family Staffing Solutions

Arosa — the in-home care company backed by Bain Capital Double Impact and formerly known as Arosa+LivHome — is ramping up its M&A activity in 2021. Toward the beginning of the year, Arosa entered the New Jersey market following the acquisition of Aveanna Concierge Services. On Monday, the in-home care provider announced it has now …

Arosa Acquires Family Staffing Solutions Read More »

Coltala Acquires Choice Health at Home: ‘We Recognized an Opportunity — and Paid a Good Price for It’

The private equity firm Coltala Holdings has acquired a stake in Choice Health at Home, a growing home-based care provider based in Texas. Financial details were not disclosed. The capital and other resources from Coltala will help Choice become a larger home health player across the South. Additional aspects of the deal reflect larger trends …

Coltala Acquires Choice Health at Home: ‘We Recognized an Opportunity — and Paid a Good Price for It’ Read More »

AccentCare Enters Two New Markets with Purchase of Southeastern Health Care at Home

AccentCare announced Monday that it has purchased Southeastern Health Care at Home from private equity firm Geneva Glen Capital. Southeastern Health Care at Home is the largest privately-owned home health services provider in Pennsylvania. In addition to home health care, the company delivers hospice and mobile primary care services, plus palliative and wound care services. …

AccentCare Enters Two New Markets with Purchase of Southeastern Health Care at Home Read More »

Pennant Acquires First Call Hospice; Humana Grows CenterWell Footprint

Pennant adds end-of-life care provider The Pennant Group Inc. (PNTG) has acquired the assets of First Call Hospice, an end-of-life care provider that operates in Sacramento, California. Financial terms of the acquisition, effective June 16, were not disclosed. The Eagle, Idaho-based Pennant is the parent organization of a group of affiliated home health, hospice, home …

Pennant Acquires First Call Hospice; Humana Grows CenterWell Footprint Read More »

Help at Home Reportedly Planning to Go Public by Year’s End

Help at Home — a provider of home- and community-based services (HCBS) — is considering going public. The Chicago-based company has even selected banks to help it prepare for an IPO later this year, Bloomberg News reported. More providers are considering public exits thanks to an increasing demand for home-based care, promising outlooks for public …

Help at Home Reportedly Planning to Go Public by Year’s End Read More »

Roivant spinout Datavant merges with Ciox to form $7bn health data giant

Datavant and Ciox Health have agreed a merger that will create what they claim will be the largest health data company operating in the US market. The combined company – which will take the Datavant name – will be worth around $7 billion and have annual revenues of around $700 million, according to the two …

Roivant spinout Datavant merges with Ciox to form $7bn health data giant Read More »

How Home Health Care Helped Shape the $34B Medline Megadeal

A group of private equity firms have reached an agreement to acquire a controlling stake in Medline Industries Inc., a major player in the medical-supply space that works across the continuum of care. Announced Saturday, the deal reportedly places a $34 billion enterprise value on the Northfield, Illinois-based Medline. While the megadeal likely won’t directly …

How Home Health Care Helped Shape the $34B Medline Megadeal Read More »

Bayada, VCU Health System Form New Joint Venture; Choice Health Makes Multiple Acquisitions

Bayada’s new home health JV Bayada Home Health Care and VCU Health System have formed a new home health and hospice joint venture in Richmond, Virginia. The new company, named “VCU Health at Home by Bayada,” is expected to start accepting patients within the next six to nine months. The enterprise will serve patients in …

Bayada, VCU Health System Form New Joint Venture; Choice Health Makes Multiple Acquisitions Read More »

Bayer props up sagging radionuclide business with Noria acquisition

Bayer has agreed to buy Noria Therapeutics and its subsidiary PSMA Therapeutics, adding to its pipeline of radionuclide drugs for cancer as sales of its lead product in the category – Xofigo – continue to decline.  Just over three years ago, Bayer was forced to concede that its blockbuster expectations for Xofigo (radium Ra 223 …

Bayer props up sagging radionuclide business with Noria acquisition Read More »

MorphoSys to Acquire Constellation Pharmaceuticals for ~$1.7B

Shots: MorphoSys to acquire all of the outstanding shares of Constellation’s common stock for $34.00/ share in cash making a total equity value of $1.7B. The transaction is expected to close in Q3’21 The acquisition will bolster Morphosys’ position in hematology-oncology & accelerates growth strategy with the addition of Constellation’s Pelabresib (CPI-0610) & CPI-0209 Additionally, …

MorphoSys to Acquire Constellation Pharmaceuticals for ~$1.7B Read More »

Addus Focused on Sourcing New Home Health Acquisitions, Improving Applicant-Conversion Rates

The COVID-19 public health emergency has solidified the home as a viable and effective care setting. That, in turn, has led to meaningful opportunities for home-based care providers, especially those with diversified service lines. Addus HomeCare Corporation (Nasdaq: ADUS) is a prime example. The company’s leadership team discussed the pandemic and its lasting impacts during …

Addus Focused on Sourcing New Home Health Acquisitions, Improving Applicant-Conversion Rates Read More »

LHC Group Bides Its Time on Home Health M&A, Inks Another Hospice Deal

In-home care powerhouse LHC Group Inc. (Nasdaq: LHCG) has reached an agreement to acquire Heart of Hospice, an end-of-life care provider with locations in five states. Financial terms of the deal were not disclosed. The transaction announcement comes a week after LHC Group unveiled similar plans to buy Idaho-based Heart ‘n Home Hospice for an …

LHC Group Bides Its Time on Home Health M&A, Inks Another Hospice Deal Read More »

MorphoSys offers $1.7bn for Constellation, but investors see stars

Shares in German biotech MorphoSys have gone on the slide after it announced a $1.7 billion deal to buy its US rival Constellation Pharma and its pipeline of cancer and haematology therapies. MorphoSys said the $34 per share deal would accelerate growth by adding two clinical-stage drug candidates, namely BET inhibitor pelabresib (CPI-0610) in phase …

MorphoSys offers $1.7bn for Constellation, but investors see stars Read More »

Searchlight Capital Lands Majority Stake in Care Advantage

Funds advised by Searchlight Capital Partners have reached an agreement to acquire a majority stake in Care Advantage, one of the largest in-home care companies in the Mid-Atlantic region. Terms of the transaction were not disclosed. Founded over three decades ago, Care Advantage offers a range of in-home care services to patients across Virginia, Maryland, …

Searchlight Capital Lands Majority Stake in Care Advantage Read More »

Ashfield Engage acquires US consulting firm Nuvera LLC

Ashfield Engage has completed the acquisition of Nuvera, a US-based healthcare consulting firm specialising in patient support programmes. Ashfield Engage and Nuvera will offer integrated specialist support and services including late-phase clinical trial experience, implementation and post-commercialisation satisfaction benchmarking and service optimisation. Nareda Mills, global president, patient solutions, Ashfield Engage said the combined expertise of …

Ashfield Engage acquires US consulting firm Nuvera LLC Read More »

Aveanna Details Big Plans for Home Health M&A in First Official Earnings Call

Fresh off of its market debut last month, Aveanna Healthcare Holdings, Inc. (Nasdaq: AVAH) is throwing its weight behind home health. Since going public, the company has made moves to position itself as a major player within the home health space. Aveanna plans to aggressively pursue home health M&A opportunities, Rod Windley, executive chairman of …

Aveanna Details Big Plans for Home Health M&A in First Official Earnings Call Read More »

Vectura agrees $1.4bn takeover by private equity group Carlyle

Vectura has agreed to a £1.55 per share takeover by US private investment company Carlyle, which values the UK drug delivery specialist at £958 million ($1.4 billion).  The acquisition of one of the UK’s biggest biotech companies comes as Vectura is in the midst of a business restructuring that has seen it pivot away from …

Vectura agrees $1.4bn takeover by private equity group Carlyle Read More »

DispatchHealth Announces New Health System Partnerships; LHC Group Enters Oregon Hospice Market

DispatchHealth partners with two new health systems The in-home medical care provider DispatchHealth on Tuesday announced partnerships with Eastern Connecticut Health Network (ECHN) and Waterbury Health. The partnerships revolve around bringing patients same-day, at-home medical care. Denver-based DispatchHealth partners with health systems and payers to offer an array of services within the home. The company’s …

DispatchHealth Announces New Health System Partnerships; LHC Group Enters Oregon Hospice Market Read More »

UK competition watchdog probes AstraZeneca, Alexion merger

The antitrust authority in the UK has launched an investigation into the proposed $39 billion takeover of US firm Alexion by AstraZeneca. The Competition and Markets Authority (CMA) is starting the first phase of the probe today, and said it should wrap it up by 21 July, deciding at that point whether to start a …

UK competition watchdog probes AstraZeneca, Alexion merger Read More »

Zing Health Announces Expansion, Sets Sights on Larger Home-Based Care Partnerships

Zing Health Enterprises, a Chicago-based Medicare Advantage provider, has announced plans to expand to over 30 additional states through its pending acquisition of Lasso Healthcare. The two entities ultimately aligned on a deal because of their like-minded approach, according to Dr. Eric Whitaker, the CEO and founder of Zing Health. Lasso Healthcare and Zing Health …

Zing Health Announces Expansion, Sets Sights on Larger Home-Based Care Partnerships Read More »

How a Capital Gains Tax Hike Could Affect the Home-Based Care M&A Market

The M&A market is heating up again now that uncertainty tied to the COVID-19 crisis is waning. Another factor that could increase transactions and shift the market, though, has nothing to do with home-based care. Instead, it’s President Joe Biden’s proposed increase to the capital gains tax. Broadly, a capital gains tax is applied to …

How a Capital Gains Tax Hike Could Affect the Home-Based Care M&A Market Read More »

Under-pressure GSK sells stake in respiratory diseases partner Innoviva

GlaxoSmithKline has sold its entire stake in its respiratory partner Innoviva, raising $392 million and simplifying its business ahead of a split into two. GSK is pushing ahead with a split into an innovative drugs business and a consumer healthcare firm, while the spectre of activist investor Elliott Management hangs over it. The fund run …

Under-pressure GSK sells stake in respiratory diseases partner Innoviva Read More »

Medalogix Merges with Muse Healthcare, Gets Backing from Vistria and LHC Group

Medalogix was already one of the market leaders in home health predictive analytics. It has now gotten what appears to be another boost. That boost comes in the form of three new developments: a merger, a private equity investment and an investment from yet another publicly traded home health care giant. On Wednesday, the Chicago-based …

Medalogix Merges with Muse Healthcare, Gets Backing from Vistria and LHC Group Read More »

BlackTree, Simione Unveil ‘SimiTree’ Following Private Equity-Backed Merger

The post-acute care space has been undergoing a wave of consolidation for the past few years. And as more providers come together, the businesses that serve them are beginning to do the same. The newest example of that trend came Tuesday, when the Connecticut-based Simione Healthcare Consultants and Pennsylvania-based BlackTree Healthcare Consulting revealed plans to …

BlackTree, Simione Unveil ‘SimiTree’ Following Private Equity-Backed Merger Read More »

Why SPACs Could Shake Up the Home-Based Care M&A Environment

Special purpose acquisition companies (SPACs) have risen to immense popularity in the past 12 months. Many are becoming more intrigued by senior-focused investments as well. Ultimately, that could lead to a shift in the home-based care M&A environment. SPACs — sometimes referred to as “blank-check companies” — offer an alternative to the traditional route of …

Why SPACs Could Shake Up the Home-Based Care M&A Environment Read More »

HouseWorks Acquires Care Management Company Intervention Associates

HouseWorks — the large, independent home care organization that also runs a home-modification business — is adding another important senior care tool to its toolbox. The Boston-based HouseWorks announced Monday that it has acquired Intervention Associates, a care management company that currently serves the Greater Philadelphia area. Financial terms of the acquisition were not disclosed. …

HouseWorks Acquires Care Management Company Intervention Associates Read More »

Charles River to Acquire Vigene Biosciences for $292.5M

Shots: Charles River Laboratories to acquire Vigene in all cash transaction for $292.5M. In addition to the initial purchase price, the transaction includes contingent additional payments of up to $57.5M based on future performance The transaction is expected to be close in Q3’21. The acquisition will allow Charles River to boost its gene therapy capabilities …

Charles River to Acquire Vigene Biosciences for $292.5M Read More »

PerkinElmer to Acquire Immunodiagnostic Systems Holdings for ~$155M

Shots: PerkinElmer to acquire IDS in all cash transactions for ~$155M. The transaction is expected to be completed in Q3’21 The acquisition will allow PerkinElmer to foster its overall Diagnostics business and specifically its immunodiagnostics segment The acquisition will integrate PerkinElmer’s channel expertise and testing capabilities with IDS’ chemiluminescence products in endocrinology, autoimmunity, and infectious …

PerkinElmer to Acquire Immunodiagnostic Systems Holdings for ~$155M Read More »

AMN Healthcare Buys Synzi for $42.5M; Pennant Acquires Texas Home Health Provider

AMN scoops up Synzi Staffing powerhouse AMN Healthcare Services Inc. (NYSE: AMN) has completed its $42.5 million all-cash acquisition of full-service virtual care management company Synzi. The Dallas-based AMN offers workforce and staffing solutions across the health care continuum, from acute care hospitals and urgent care centers to home health agencies. It also delivers its …

AMN Healthcare Buys Synzi for $42.5M; Pennant Acquires Texas Home Health Provider Read More »

Long-Term Clients, Referral Sources Give Home Care Sellers an M&A Edge

In April, home care provider Family Tree In-Home Care acquired HomeCare of the Rockies. And while it seems like just another transaction, from the buyer’s perspective, it was anything but. The acquisition was Family Tree’s first since the pandemic began. Its growth strategy plans were severely delayed by the COVID-19 crisis, but the trends in …

Long-Term Clients, Referral Sources Give Home Care Sellers an M&A Edge Read More »

Encompass Health CEO: There’s Pent-Up Demand for Home Health Services

Encompass Health Corp. (NYSE: EHC) is actively evaluating ways to strategically reposition its home health and hospice segment, which also needs a new leader. The search is under way for that new segment CEO, with current CEO April Anthony — its original founder — set to step down in June. Even with all of that …

Encompass Health CEO: There’s Pent-Up Demand for Home Health Services Read More »

Visiting Nurse Association to Sell Home Health, Hospice Operations to Amedisys

Amedisys Inc. (Nasdaq: AMED) expected to do plenty of dealmaking heading into 2020 and Year 1 of the Patient-Driven Groupings Model (PDGM). Those plans, however, were largely put on pause for the Baton Rouge, Louisiana-based home health, hospice and personal care services company due to the COVID-19 pandemic. While Amedisys remained active on the M&A …

Visiting Nurse Association to Sell Home Health, Hospice Operations to Amedisys Read More »

InnovAge CEO: ‘We Have a Couple of Irons in the Fire’

Even though InnovAge (Nasdaq: INNV) is already one of the largest Program of All-Inclusive Care for Elderly (PACE) providers in the U.S., the company has plans to go after an even bigger piece of the pie. Maureen Hewitt, president and CEO of InnovAge, talked about the company’s multi-pronged growth strategy on Monday during a conference …

InnovAge CEO: ‘We Have a Couple of Irons in the Fire’ Read More »

Home Care Innovator Lifesprk to Acquire Senior Living Operator Tealwood

Lifesprk — the whole-person senior services company based in Minnesota — has added a new page to its innovative playbook. On top of being a fully integrated provider of home health, hospice, primary care and other senior-focused services, Lifesprk is also now a bona fide senior living operator. It holds that distinction after announcing the …

Home Care Innovator Lifesprk to Acquire Senior Living Operator Tealwood Read More »

Allergan Aesthetics to Acquire Soliton and its Resonic Device for ~$550M

Shots: Soliton to receive $22.60 /share in cash for its all outstanding share making the total deal value $550M The acquisition adds Soliton’s Rapid Acoustic Pulse technology platform to Allergan Aesthetics’s portfolio for improvement in appearance of cellulite in the buttocks and thighs by using rapid high-frequency sound waves to disrupt targeted cellular structures and …

Allergan Aesthetics to Acquire Soliton and its Resonic Device for ~$550M Read More »

Simplura Is First Block in ModivCare’s Mission to Build $1B Personal Care Business

Ever since ModivCare Inc. (Nasdaq: MODV) entered the personal care space with a major acquisition last year, it has been working to solidify its place in the larger social determinants of health movement. ModivCare completed its personal care-focused acquisition of Simplura last November. The acquisition was an all-cash transaction that placed an enterprise value of …

Simplura Is First Block in ModivCare’s Mission to Build $1B Personal Care Business Read More »

Walmart to acquire telehealth firm MeMD

Walmart is to acquire telehealth provider MeMD, the companies announced as the retail giant continues with its move into digital healthcare. In statement, Walmart said it wants to use data and technology to improve engagement with healthcare services, health equity and outcomes. Over the coming months the acquisition will allow Walmart to provide access to …

Walmart to acquire telehealth firm MeMD Read More »

Addus Encouraged by Vaccine Progress, New HCBS Policies

Typically, when executives talk about their companies “having to weather the storm,” they’re speaking figuratively. That wasn’t the case for Addus HomeCare Corporation (Nasdaq: ADUS) on Tuesday. Addus CEO and Chairman Dirk Allison talked about the negative impact that the February winter storms had on the home-based care provider’s business during the company’s Q1 2021 …

Addus Encouraged by Vaccine Progress, New HCBS Policies Read More »

Roivant Going Public Via MAAC SPAC Merger for ~$7.3B

Shots: Roivant signs a SPAC merger with MAAC for ~7.3B including $411M in cash in the MAAC trust account and $200M in PIPE stock at $10.00/share. The transaction is expected to deliver ~$611M to fund discovery and development programs and is expected to close in Q3’21 Roivant equity holders and Patient Square Capital have agreed …

Roivant Going Public Via MAAC SPAC Merger for ~$7.3B Read More »

LHC Group Expands Texas Joint Venture; Anthem Completes myNEXUS Acquisition

LHC Group announces JV expansion LHC Group Inc. (Nasdaq: LHCG) as well as partners Texas Health Resources and Methodist Health System are expanding their joint venture in Texas. The three health care organizations announced on Thursday that they’re purchasing and sharing ownership of Regent Home Health, a provider that currently serves patients and families in …

LHC Group Expands Texas Joint Venture; Anthem Completes myNEXUS Acquisition Read More »

AZ posts solid Q1 results as Alexion merger looms

AstraZeneca’s not-for-profit coronavirus vaccine has bit into margins in Q1, although revenues were ahead of expectations as the company heads towards completion of its $39bn acquisition of Alexion.  The company posted Q1 product sales of $7.26bn, ahead of consensus forecasts of around $6.84 billion, with total revenues up 15% compared with last year’s Q1 to …

AZ posts solid Q1 results as Alexion merger looms Read More »

Looking to Build Market Share, Amedisys Rolls Out SNF-at-Home Pilot Program

Amedisys Inc. (Nasdaq: AMED) hasn’t been shy about the company’s plans to gain an even larger share of business from other post-acute care operators. With that in mind, the company has been focused on setting up shop in the SNF-at-home space, pairing skilled home health care with non-medical personal care services. Those efforts have now …

Looking to Build Market Share, Amedisys Rolls Out SNF-at-Home Pilot Program Read More »

Alcon to Acquire Exclusive US Commercialization Rights to Novartis’ Simbrinza

Shots: Novartis to receive $355M following the closure of acquisition, which is expected to occur in Q2’21. The acquisition expands existing Alcon’s ophthalmic portfolio and strengthens its footprints in the US The companies will initiate a transition period where Novartis will continue to sell Simbrinza and transfer the profit to Alcon. Following the transition period, …

Alcon to Acquire Exclusive US Commercialization Rights to Novartis’ Simbrinza Read More »

Pfizer Acquires Amplyx to Expand its Infectious Disease Portfolio

Shots: The acquisition expands the anti-infectives pipeline with the addition of Amplyx’s P-II candidate, Fosmanogepix (APX001) which is being evaluated in both IV and oral formulations for the treatment of patients with invasive fungal infections Pfizer also retains ownership of the Amplyx early-stage pipeline, including antiviral (MAU868) and antifungal (APX2039) therapies. The acquisition follows an …

Pfizer Acquires Amplyx to Expand its Infectious Disease Portfolio Read More »

Why Humana Believes It Can Do Home Health Care Better

Humana Inc. (NYSE: HUM) believes it can deliver home health services better than traditional providers do today. More than any other reason, that’s fundamentally why it’s accelerating its in-home care strategy by acquiring 100% of home health giant Kindred at Home for a “bargain” purchase price of $5.7 billion — the company’s largest acquisition ever. …

Why Humana Believes It Can Do Home Health Care Better Read More »

Humana to Acquire All of Kindred at Home, Divest Hospice and Community Care Operations

When Humana Inc. (NYSE: HUM) teamed up with private equity giants TPG Capital and Welsh, Carson, Anderson & Stowe (WCAS) to acquire Kindred Healthcare in July 2018, it was only a matter of time before the Louisville, Kentucky-based health insurer went off on its own. That time has finally arrived. As part of that $4.1 …

Humana to Acquire All of Kindred at Home, Divest Hospice and Community Care Operations Read More »

DispatchHealth Makes First Acquisition, Acquires Mobile Imaging Company

DispatchHealth has officially transitioned from “up-and-coming startup” to “active acquirer.” The company announced Tuesday that it has made its first-ever purchase by landing Professional Portable X-Ray (PPX), a mobile imaging provider. Financial terms of the transaction were not disclosed. Denver, Colorado-based DispatchHealth offers hospital-at-home and mobile high-acuity services through its emergency medicine-trained teams. It currently …

DispatchHealth Makes First Acquisition, Acquires Mobile Imaging Company Read More »

PE-Backed Valeo Acquires Post-Acute Care Business; BrightSpring Finalizes Abode Deal

Valeo Home Health lands Hearts for Hospice & Home Health Valeo Home Health & Hospice has acquired Hearts for Hospice & Home Health from Abode Healthcare. Valeo is PE-backed provider based in Millcreek, Utah, that provides a mix of post-acute care services Strategically, the acquisition increases Valeo’s presence in Utah, as Hearts for Hospice & …

PE-Backed Valeo Acquires Post-Acute Care Business; BrightSpring Finalizes Abode Deal Read More »

Encompass Health Pens Deal to Acquire Home Health Assets of Frontier

Ahead of this week’s upcoming earnings call, Encompass Health Corp. (NYSE: EHC) has locked in an agreement to acquire the home-based care assets of Frontier Home Health and Hospice. The company announced the news Monday. The financial terms of the deal were not disclosed. Birmingham, Alabama-based Encompass Health delivers care in both facility- and home-based …

Encompass Health Pens Deal to Acquire Home Health Assets of Frontier Read More »

Skyrocketing Home Health Demand, Better Care Coordination Drove HCA Healthcare to Brookdale

HCA Healthcare (NYSE: HCA) is the largest health system in the U.S. That scale alone has made its entrance into the home health space worth paying attention to. In February, HCA announced that it had entered into a definitive agreement to acquire a majority stake in Brookdale Senior Living’s (NYSE: BKD) up-and-down home health and …

Skyrocketing Home Health Demand, Better Care Coordination Drove HCA Healthcare to Brookdale Read More »

Indigo Medical merges with imc group

Indigo Medical, a provider of material review, medical signatory approval services and medical communication for global pharmaceutical and biopharma companies, is joining imc group with the backing of pan-European investor Waterland Private Equity. In a statement the companies said the merger will help imc provide a one-stop service for clients across seven core divisions: Medical …

Indigo Medical merges with imc group Read More »

SparingVision Acquires GAMUT Therapeutics to Expands its Novel Ocular Disease Pipeline

Shots: The acquisition expands SparingVision’s ocular genomic medicine pipeline with the addition of GAMUT’s lead product SPVN20, which is a novel, mutation-agnostic gene therapy, focuses on restoring the function of dormant cone cells in the retina. The acquisition is expected to close in Q2’21 SparingVision plans to evaluate the therapeutic synergy with a combination of …

SparingVision Acquires GAMUT Therapeutics to Expands its Novel Ocular Disease Pipeline Read More »

Microsoft puts AI at heart of digital health strategy with Nuance deal

Microsoft has made its aspirations in digital health clear with a whopping $19.7 billion deal to buy Nuance Communications and its artificial intelligence platform for speech recognition that is increasingly being used for clinical applications.  The $56 per share deal is all about increasing Microsoft’s position in digital health, and represents a hefty multiple on …

Microsoft puts AI at heart of digital health strategy with Nuance deal Read More »

Amedisys, Charter Keep Home Health M&A Train Rolling

The home health dealmaking train keeps on rolling, with the latest transactions coming from Amedisys Inc. (Nasdaq: AMED) and Charter Health Care Group, a private equity-backed post-acute care provider. On Wednesday, the Baton Rouge, Louisiana-based Amedisys announced it signed a definitive agreement to acquire the regulatory assets of a home health provider operating in Randolph …

Amedisys, Charter Keep Home Health M&A Train Rolling Read More »

Avantor to Acquire Ritter and its Affiliates for ~$1.06B

Shots: Avantor to acquire Ritter and its affiliates in an all-cash transaction with an up front equity purchase price of ~ $1.06B along with additional payments following the achievement of milestones. The transaction is expected to be completed in Q3’21 The acquisition expands Avantor’s offering for diagnostic and drug discovery workflows The acquisition integrates Ritter’s …

Avantor to Acquire Ritter and its Affiliates for ~$1.06B Read More »

DiaSorin to Acquire Luminex for ~$1.8B

Shots: DiaSorin to acquire Luminex for $37.00/ share in an all-cash transaction, with 23% premium based on closing stock price of Luminex on 24 Feb, 2021, making a total equity value of $1.8B The acquisition will boost DiaSorin’s presence in the molecular diagnostics space in the US with the addition of Luminex’s molecular diagnostics multiplexing …

DiaSorin to Acquire Luminex for ~$1.8B Read More »

Microsoft to Acquire Nuance for ~$19.7B

Shots: Microsoft to acquire all outstanding shares of Nuance for $56.00/ share, making a total deal value of $19.7B in cash with a premium of 23% to Nuance closing price on Apr 09, including its net debt. The transaction is expected to close in 2021 The acquisition builds on Microsoft’s efforts to deliver new cloud …

Microsoft to Acquire Nuance for ~$19.7B Read More »

Report: Fewer health system M&A deals in Q1 2021 offset by larger transactions

Though the number of merger and acquisition deals in the first quarter of 2021 fell below historical averages, the size of the deals was far bigger than the same period last year, a new report from Kaufman Hall shows. The total transacted revenue was $8.8 billion, the second-highest Q1 figure in the last five years.

Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity

The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response.  Within the Health IT industry, the already strong investment and M&A trends seen in 2020 have only accelerated.  Over the course of the quarter, we observed $7 billion in private …

Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity Read More »

Fishawack buys health economics consultancy PRMA

UK comms agency Fishawack Health has acquired the health economics outcomes research (HEOR) consultancy PRMA Consulting. PRMA has offices across Europe, Asia and the US and adds expertise in Asia-Pacific and European markets to the company’s market access offering in North America. The company said that the acquisition will allow it to offer a HEOR …

Fishawack buys health economics consultancy PRMA Read More »

Sanofi to Acquire Tidal Therapeutics for ~$470M

Shots: Sanofi to acquire Tidal Therapeutics for $160M up front and ~ $310M following the achievement of certain milestones The acquisition will add Tidal’s innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas With its acquisition, Sanofi will further develop the technology platform to expand its research capabilities in immuno-oncology and …

Sanofi to Acquire Tidal Therapeutics for ~$470M Read More »

Hologic to Acquire Mobidiag for ~ $795M

Shots: Hologic to acquire Mobidiag for ~$795M which includes ~$714M in cash for Mobidiag’s equity and debt of $81M. The acquisition is expected to close in Q4’21 The acquisition will accelerate Hologic’s global footprints by enabling it to expand into the large, fast-growing acute care adjacency with a near-patient testing solution that offers ease of …

Hologic to Acquire Mobidiag for ~ $795M Read More »

Dedalus Completes Acquisition of DXC’s Provider Healthcare Business – M&A Analysis

What You Should Know: Last week saw Dedalus complete the purchase of DXC’s healthcare provider business for $450M, a deal that was originally announced in July 2020.   – DXC was created in 2017 via the merger of CSC and the Enterprise Services business of Hewlett Packard Enterprise (HPE) – Dedalus has been through a rapid …

Dedalus Completes Acquisition of DXC’s Provider Healthcare Business – M&A Analysis Read More »

Health Care-Focused PE Firm RiverGlade Capital Acquires Home Helpers

Home care M&A experts knew that the dealmaking dominoes would start to tumble in 2021, pushed over by the recent agreement between Senior Helper and Advocate Aurora Enterprises. They didn’t know how fast that chain reaction would be, however. On Thursday, H.H. Franchising Systems Inc. — the Cincinnati-based company that operates Home Helpers Home Care …

Health Care-Focused PE Firm RiverGlade Capital Acquires Home Helpers Read More »

PE Players Getting More Collaborative in Home Care Dealmaking

The recent upswing in home care dealmaking activity driven by private equity continues. It appears PE buyers are starting to get more collaborative, too. On Tuesday, a consortium of private equity firms came together to acquire Aging With Comfort, an independently owned Philadelphia-based home care agency that provides personal care assistance for elderly and disabled …

PE Players Getting More Collaborative in Home Care Dealmaking Read More »

Senior Helpers Likely to Be the First of Many Home Care Dominoes to Fall in 2021

Last week, the investment arm of Advocate Aurora Health acquired Senior Helpers, the giant home care franchise organization that domestically operates across 44 states. Advocate Aurora Enterprises pulled the trigger on the Maryland-based Senior Helpers as part of its three-pronged investment thesis around aging, parenthood and well-being. According to a report from PE Hub, Advocate’s …

Senior Helpers Likely to Be the First of Many Home Care Dominoes to Fall in 2021 Read More »

Sorrento to Acquire ACEA Therapeutics for ~$488M

Shots: ACEA to receive up to ~$38M in shares of Sorrento common stock, $450M as additional payments upon the achievement of clinical & sales milestones along with 5 – 10% royalties based on annual sales of each product. The acquisition is expected to close in Q2’ 21 The acquisition includes Abivertinib, AC0058, AC0939, and ACEA’s …

Sorrento to Acquire ACEA Therapeutics for ~$488M Read More »

Brookdale’s Home Health Business May Look ‘Drastically Different’ Under HCA Healthcare

In late February, HCA Healthcare (NYSE: HCA) announced it had entered into a definitive agreement to acquire a majority stake in Brookdale Senior Living’s (NYSE: BKD) home health and hospice business. A for-profit operator of health care facilities like HCA wanting to ride home health tailwinds isn’t surprising. But HCA is a completely new — …

Brookdale’s Home Health Business May Look ‘Drastically Different’ Under HCA Healthcare Read More »

Mission Healthcare Purchases Loma Linda University Medical Center’s Home Health Segment

Mission Healthcare has acquired Loma Linda University Medical Center Home Health in Southern California. Loma Linda University Medical Center Home Health is a part of Loma Linda University Health, which includes eight professional schools, six hospitals and a network of more than 900 faculty physicians. Meanwhile, San Diego, California-based Mission Healthcare is one of the …

Mission Healthcare Purchases Loma Linda University Medical Center’s Home Health Segment Read More »

Aveanna Files for $100M IPO, Announces Major Expansion Plans

Aveanna Healthcare Holdings Inc. — a large and rapidly growing in-home care company that historically has specialized in caring for complex pediatric patients — is attempting to go public. The Atlanta-based home health provider announced plans to raise $100 million in an initial public stock offering on Thursday. In its paperwork, Aveanna also revealed an …

Aveanna Files for $100M IPO, Announces Major Expansion Plans Read More »

The Pennant Group Acquires Colorado Home Health Agency

After announcing that it has aspirational growth plans for 2021, The Pennant Group Inc. (Nasdaq: PNTG) delivered on Thursday, as it announced the acquisition of a Colorado home health agency. The Eagle, Idaho-based Pennant Group is the parent company of affiliated home health, hospice and senior living companies. Included in its network are 84 home …

The Pennant Group Acquires Colorado Home Health Agency Read More »

[Updated] ‘We Own the Full Health Care Continuum’: Advocate Aurora Enterprises Acquires Senior Helpers

One of the largest home care organizations in the country has been acquired by one of the nation’s biggest health systems. Advocate Aurora Enterprises — the recently established subsidiary of Midwest-based Advocate Aurora Health, one of the 12 largest not-for-profit, integrated health systems in the U.S. — announced Thursday it has acquired Senior Helpers. The …

[Updated] ‘We Own the Full Health Care Continuum’: Advocate Aurora Enterprises Acquires Senior Helpers Read More »

Precision Value & Health acquires Across Health

Pharma marketing specialist Precision Value & Health has acquired the specialist communications consultancy Across Health. Across Health is a leading global omnichannel engagement consultancy focused on providing clients an analytical and evidence-based framework for commercial strategy, execution, and resource optimisation. The company’s solutions are based around its proprietary Navigator365 product suite, which more than 40 …

Precision Value & Health acquires Across Health Read More »

Immunai Acquire Dropprint Genomics to Expand its Target Discovery Capabilities

Shots: Immunai acquires the Dropprint Genomics and also expand its team with the hiring of new experts in immunology, single-cell technologies and machine learning The acquisition and the new hiring will advance the Immunai’s work in single cell functional genomics to support discovery, prioritization, and development of new therapies and drug combinations The acquisition happened …

Immunai Acquire Dropprint Genomics to Expand its Target Discovery Capabilities Read More »

Anthem to Buy Home-Based Care Management Company myNEXUS

Anthem Inc. (NYSE: ANTM) is bolstering its home-based care capabilities. The Indianapolis-based health insurer announced Wednesday that it has entered into an agreement to buy myNEXUS Inc., a technology-enabled company that manages home-based care for payers. Financial terms of the agreement were not disclosed. “Providing timely care for members in their homes allows for both …

Anthem to Buy Home-Based Care Management Company myNEXUS Read More »

Rumored Appriss Acquisition Values Care Collaboration Company PatientPing at $500M

Care collaboration software platform PatientPing has reportedly been acquired. Boston-based PatientPing provides a wide range of services, including real-time notifications when patients receive care, COVID-19-monitoring tools and other solutions. The software company works with health care organizations across the continuum of care, from hospitals and health systems to post-acute care providers. Citing “people familiar with …

Rumored Appriss Acquisition Values Care Collaboration Company PatientPing at $500M Read More »

Cardinal Health to Divest its Cordis Business to Hellman & Friedman for $1B

Shots: Cardinal Health signed an agreement to divest its Cordis medical device business to H&F for ~ $1B including liabilities and working capital accounts. The transaction is expected to close in the H1’ 22 Following the completion of the agreement, H&F will assume most of the Cordis assets and liabilities while Cardinal Health will retain …

Cardinal Health to Divest its Cordis Business to Hellman & Friedman for $1B Read More »

Roche expands COVID testing portfolio with $1.8bn GenMark deal

Roche has said it will pay $1.8 billion for molecular testing company GenMark, boosting the Swiss company’s diagnostic capabilities and adding rapid COVID tests to its pandemic arsenal.  GenMark’s tests are designed to rapidly detect multiple pathogens from a single patient sample. Of particular interest at the moment are its Respiratory Pathogen Panels, which identify …

Roche expands COVID testing portfolio with $1.8bn GenMark deal Read More »

Roche to Acquire GenMark Diagnostics for $1.8B

Shots: Roche to acquire all outstanding shares of GenMark’s for $24.05/ share in cash, making a total deal value of $1.8B with a premium of ~43% to GenMark’s closing price on Feb 10, 2021. The acquisition is expected to be completed in Q2’21 The acquisition will boost Roche’s molecular diagnostics portfolio and will expand the …

Roche to Acquire GenMark Diagnostics for $1.8B Read More »

Mission Healthcare Plans Palliative Care Rollout, Multi-State Expansion

Mission Healthcare — one of the largest regional home health, hospice and palliative care providers in Southern California — is on the move. Earlier this month, the San Diego-based company completed its acquisition of Alliance Home Health & Hospice Care, a Medicare-certified home health and hospice organization in Pleasanton. The acquisition is Mission’s first outside …

Mission Healthcare Plans Palliative Care Rollout, Multi-State Expansion Read More »

Grifols Acquires Remaining 56% of GigaGen for ~$80M

Shots: Grifols acquires the remaining 56% share of GigaGen for $80M. The acquisition will add GigaGen’s pipeline of recombinant polyclonal Abs, including GIGA-2050 and boost Grifol’s portfolio if I-O therapies Earlier, in 2017, Grifols acquired a 44% stake in GigaGen, when the two companies collaborated to develop polyclonal antibodies under a $50M pact GIGA-2050 is …

Grifols Acquires Remaining 56% of GigaGen for ~$80M Read More »

Takeda buys Maverick as T-Cell engager research hots up

Takeda is taking its option to buy the privately held biotech Maverick Therapeutics and its T-Cell engager cancer therapies for $525 million, as research into the technology gathers pace. San Francisco-based Maverick’s technology is designed to target solid tumours with a T-cell attack that focuses on cancerous tissues while leaving healthy tissue alone. Standard T-cell …

Takeda buys Maverick as T-Cell engager research hots up Read More »

Takeda to Acquire Maverick for ~$525M

Shots: Takeda exercised its option to acquire Maverick for up to $525M up front as well as development and regulatory milestones including Takeda’s current equity stake and Maverick debt. The acquisition is expected to finalize in Q1’21 The acquisition will expand Takeda’s I-O portfolio with the addition of two development candidates (MVC-101 & MVC-280) and …

Takeda to Acquire Maverick for ~$525M Read More »

CareFinders Total Care Reportedly Pursuing Growth Capital

One of the faster-growing home care organizations in the United States is now trying to grow even faster. PE Hub reported Monday that CareFinders Total Care is trying to lock down additional growth capital. Hackensack, New Jersey-based CareFinders provides home care services to more than 8,500 patients throughout New Jersey, Pennsylvania and Connecticut. The company …

CareFinders Total Care Reportedly Pursuing Growth Capital Read More »

Agilent to Acquire Resolution Bioscience for $695M

Shots: Resolution to receive $550M in cash at closing and ~$145M following the achievement of certain milestones. The transaction is expected to close in Apr’2021 The acquisition will expand Agilent’s capabilities in NGS-based cancer diagnostics and strengthen its position in precision oncology testing globally The acquisition will bring together Resolution’s noninvasive liquid biopsy platform that …

Agilent to Acquire Resolution Bioscience for $695M Read More »

Amgen to Acquire Five Prime for ~$1.9B

Shots: Amgen to acquire all of the outstanding shares of Five Prime for $38.00 /share in cash, representing an equity value of ~ $1.9B. The transaction is expected to close in Q2’21 The acquisition will add Five Prime’s innovative pipeline to Amgen thus expanding its oncology portfolio and supports its international expansion strategy Five Prime’s …

Amgen to Acquire Five Prime for ~$1.9B Read More »

Home Health M&A Experts Seeing Fewer ‘Fire Sales’ Tied to PDGM, COVID-19

The historic wave of consolidation that home health M&A experts predicted ahead of the Patient-Driven Grouping Model (PDGM) hasn’t fully panned out, largely due to the COVID-19 emergency and the billions in federal relief dollars that have come with it. There was some degree of contraction within the industry, however. Going into 2020, there was …

Home Health M&A Experts Seeing Fewer ‘Fire Sales’ Tied to PDGM, COVID-19 Read More »

Boston Scientific Signs an Agreement with BPEA to Acquire Lumenis’ Surgical Business

Shots: Boston Scientific to acquire the global surgical business of Lumenis for $1.07B as an up front in cash. The transaction is expected to be completed in H2’21 BPEA will retain ownership of the Lumenis global aesthetics and ophthalmology businesses. The acquisition will expand Boston Scientific’s global kidney stone management portfolio and will expand its …

Boston Scientific Signs an Agreement with BPEA to Acquire Lumenis’ Surgical Business Read More »

Fusion to Acquire Ipsen’s IPN-1087 to Expand its Pipeline of Radiopharmaceuticals

Shots: Ipsen to receive 400,000 shares at closing and an additional 200,000 shares as milestones, $81.63M as development and regulatory milestones & $423.24M as commercial milestones along with royalties on net sales Fusion will be responsible for paying to a third-party licensor up to $84.7M in development milestones and royalties on net sales of products …

Fusion to Acquire Ipsen’s IPN-1087 to Expand its Pipeline of Radiopharmaceuticals Read More »

Numan buys Vi Health to add digital capabilities

Numan has added to its digital health stable with the acquisition of Sweden’s Vi Health and its suite of tools including an artificial intelligence-powered symptom checker.  UK-based Numan is in the process of building a digital health platform to provide access to medical professionals as well as information on pharmaceutical products and health conditions, around …

Numan buys Vi Health to add digital capabilities Read More »

AbbVie Signs a Purchase Right Agreement to Acquire Mitokinin

Shots: Mitokinin to receive an up front and will continue to develop its PINK1 activator program through completion of IND enabling studies for its lead compound. If IND-enabling studies are successful, AbbVie will have the option to acquire Mitokinin The focus of the agreement is to advance Mitokinin’s PINK1 activator program to treat PD Mitokinin’s …

AbbVie Signs a Purchase Right Agreement to Acquire Mitokinin Read More »

LHC Group Expands In-Home Care Partnership with Orlando Health

LHC Group Inc. (Nasdaq: LHCG) and Orlando Health announced Tuesday they are expanding their joint venture into St. Petersburg, Florida, by realigning Bayfront Home Health Services into the partnership’s portfolio. Bayfront Home Health Services was already owned by LHC Group, but now the home health provider will be controlled through the joint venture. “Bayfront Home …

LHC Group Expands In-Home Care Partnership with Orlando Health Read More »

Hologic to Acquire Diagenode for ~$159M

Shots: Hologic to acquire Diagenode for ~$159M. The transaction will expand and diversifies Hologic’s diagnostic business across test menu, customer segments and geography The acquisition will strengthen Hologic’s molecular diagnostics business by expanding international its capabilities and allow it to offer a broader more differentiated test menu Diagenode and Hologic previously collaborated to develop Hologic’s …

Hologic to Acquire Diagenode for ~$159M Read More »

Roivant to Acquire Silicon Therapeutics for ~$450M

Shots: Roivant to acquire Silicon for $450M in Roivant’s equity with additional potential regulatory and commercial milestones. The acquisition will strengthen Roivant’s AI capabilities for drug discovery The acquisition of Silicon will bolster Roivant’s targeted protein degradation platform that will be powered by VantAI’s ML techniques The integration of Silicon and VantAI will allow Roivant …

Roivant to Acquire Silicon Therapeutics for ~$450M Read More »

EVV Difficulties Creating M&A Opportunities for Addus HomeCare Corporation

Over the last few months, Addus HomeCare Corporation (Nasdaq: ADUS) has had to deal with a challenging legislative environment and significant COVID-19 surges that have affected clients and caregivers alike. Still, the Frisco, Texas-based in-home care provider is maintaining its course, particularly when it comes to M&A activity in 2021. “We continue to evaluate and …

EVV Difficulties Creating M&A Opportunities for Addus HomeCare Corporation Read More »

Merck to Acquire Pandion for ~$1.85B

Shots: Merck to acquire all outstanding share of Pandion for $60/share in cash, representing the equity value of ~$1.85B. The transaction is expected to close in H1’21 The acquisition will strengthen Merck’s portfolio with the addition of candidates targeting a broad range of autoimmune diseases Pandion is advancing a pipeline of precision immune modulators targeting …

Merck to Acquire Pandion for ~$1.85B Read More »

Why the $400M HCA Deal Is a ‘Win-Win Transaction’ for Brookdale

Brookdale Senior Living Inc. (NYSE: BKD) revealed Wednesday that it’s selling an 80% stake in its health care services business to HCA Healthcare (NYSE: HCA) for $400 million. At first glance, the transaction could be interpreted as a savvy move that enables Brookdale to cash in on its sizable home health, hospice and outpatient therapy …

Why the $400M HCA Deal Is a ‘Win-Win Transaction’ for Brookdale Read More »

Pennant Plans to ‘Put Capital to Work’ in Its Home Health Business

The Pennant Group Inc. (Nasdaq: PNTG) is sitting on a newly increased revolving line of credit, giving it plenty of M&A firepower to work with moving forward. The company specifically plans on putting “a lot of capital to work” in its home health business, executives noted during a Thursday earnings call. The Eagle, Idaho-based Pennant …

Pennant Plans to ‘Put Capital to Work’ in Its Home Health Business Read More »

Merck takes on Lilly/Nektar in IL-2 with $1.85bn Pandion buy

Merck & Co/MSD has agreed to buy Pandion for $1.85 billion, bolting on a pipeline of drugs for autoimmune and other immunological disorders headed by interleukin-2 (IL-2) based therapy PT-101.  The $60 per share is a handsome, more than 100% premium on Pandion’s closing share price yesterday, and gives Merck a foothold in the hot …

Merck takes on Lilly/Nektar in IL-2 with $1.85bn Pandion buy Read More »

BrightSpring Reportedly Acquires Abode in $775M Deal

BrightSpring Health Services has reportedly brokered a deal to acquire Abode Hospice and Home Health, according to PE Hub. Based in Louisville, Kentucky, BrightSpring provides a diverse array of home- and community-based services, serving more than 350,000 patients across 50 states. In 2019, BrightSpring was acquired by global investment firm KKR, with Walgreens Boots Alliance …

BrightSpring Reportedly Acquires Abode in $775M Deal Read More »

BrightSpring Reportedly Acquires Adobe Healthcare in $775M Deal

BrightSpring Health Services has reportedly brokered a deal to acquire home health provider Abode Healthcare, according to PE Hub. Based in Louisville, Kentucky, BrightSpring provides a diverse array of home- and community-based services, serving more than 350,000 patients across 50 states. In 2019, BrightSpring was acquired by global investment firm KKR, with Walgreens Boots Alliance …

BrightSpring Reportedly Acquires Adobe Healthcare in $775M Deal Read More »

UnitedHealth’s Optum Reportedly Strikes Deal for Landmark Health

Optum, a part of UnitedHealth Group (NYSE: UNH), has reportedly reached a deal to acquire in-home medical group Landmark Health. Rumors of such a deal between UnitedHealth and Landmark come from M&A intelligence service Mergermarket, which cited “four sources familiar with the situation.” Landmark declined a request for comment from Home Health Care News, which …

UnitedHealth’s Optum Reportedly Strikes Deal for Landmark Health Read More »

LSD biotech MindMed buys digital trial firm HealthMode

Psychedelic medicine biotech MindMed is to acquire digital medicine and therapeutics startup HealthMode for around $32.2 million, which uses artificial intelligence (AI) technology to speed up drug development. The move will also see ex-Pfizer digital medicine executive Dr Daniel Karlin join the MindMed executive team, along with former Google AI guru Bradford Cross. MindMed will …

LSD biotech MindMed buys digital trial firm HealthMode Read More »

Pharos-Backed Charter Buys Physmed Home Health Care; SCAN Group Invests in Monogram

The hot start to the 2021 dealmaking season continues. Pharos Capital announced on Tuesday that its post-acute care provider platform, Charter Health Care Group, has acquired two home health and hospice assets in Omaha, Nebraska. Financial terms of the transaction were not disclosed. Founded in 2006, Charter offers a range of post-acute care services, including …

Pharos-Backed Charter Buys Physmed Home Health Care; SCAN Group Invests in Monogram Read More »

Sharecare to Go Public in SPAC IPO Deal, Reaching $3.9B Valuation

What You Should Know: – Digital health company Sharecare and special purpose acquisition company (SPAC), Falcon Capital Acquisition Corp, today announced an agreement to merge to go public on the NASDAQ under the ticker symbol SHCR at enterprise value of $3.9B. – The transaction is expected to be funded through a combination of Falcon’s $345 …

Sharecare to Go Public in SPAC IPO Deal, Reaching $3.9B Valuation Read More »

Novartis to Acquire GSK’s Cephalosporin Antibiotics Business

Shots: GSK to receive $350M at closing, along with ~$150M as milestones. The transaction is expected to close in H2’21 The transaction will allow GSK to prioritize and simplify its portfolio and invest in the company’s R&D pipeline and new product launches The agreement includes the global rights to three established brands (Zinnat, Zinacef and …

Novartis to Acquire GSK’s Cephalosporin Antibiotics Business Read More »

Signify Health Shares Soar More Than 33% in IPO, Valuing Company at Over $7.12B

What You Should Know: – Shares of Signify Health, a value-based care billing platform for in-home and bundled health services jumped more than 33% in its initial public offering (IPO), valuing the company at over $7.12B. – Today, Signify Health’s CEO Kyle Armbrester will also join the ranks among the youngest CEOs to ever take …

Signify Health Shares Soar More Than 33% in IPO, Valuing Company at Over $7.12B Read More »

In-Home Care Providers ConcertoHealth, Perfect Health Merge to Form ‘ConcertoCare’

Two in-home care providers — ConcertoHealth and Perfect Health — announced Wednesday that their organizations have merged. Together, the companies will operate under the name “ConcertoCare.” Aliso Viejo, California-based ConcertoHealth is a value-based care provider organization that delivers a variety of home-based care services. The company’s teams consist of complex care physicians, complex care nurses, …

In-Home Care Providers ConcertoHealth, Perfect Health Merge to Form ‘ConcertoCare’ Read More »

Lonza to Divest Specialty Ingredients Business to Bain Capital and Cinven for $4.7B

Shots: Bain Capital and Cinven to acquire Lonza’s specialty ingredients business and operations for an enterprise value of $4.7B. The transaction is expected to close in H2’21 The divestiture will allow Lonza to refocus its business as a pure-play partner to the healthcare industry Lonza’s specialty ingredients business provides microbial control solutions for Professional Hygiene …

Lonza to Divest Specialty Ingredients Business to Bain Capital and Cinven for $4.7B Read More »

23andMe goes public using Richard Branson’s blank cheque company

DNA testing company 23andMe has signed a deal to merge with a ‘blank cheque’ company set up by Virgin billionaire Sir Richard Branson as a shortcut to a public listing. The agreement with Branson’s VG Acquisition Corp ties in with an emerging trend among life sciences companies to forego the usual initial public offering (IPO) …

23andMe goes public using Richard Branson’s blank cheque company Read More »

23andMe Going Public Via Virgin Group SPAC Merger

Shots: 23andMe signs a SPAC merger with VGAC for an enterprise value of ~$3.5B, including $509M in cash in trust account and $250M PIPE of common stock at $10.00/share If no public shareholders of VGAC exercise their redemption rights, 23andMe will be capitalized up to $984M in cash to fund operations & support growth initiatives. …

23andMe Going Public Via Virgin Group SPAC Merger Read More »

Jazz agrees $7.2bn deal to buy cannabis meds pathfinder GW Pharma

Jazz Pharma has agreed a $7.2 billion deal to by GW Pharmaceuticals and its pioneering cannabis-derived medicines, headed by childhood epilepsy drug Epidiolex. Nasdaq-listed GW is in line for $220 per share, consisting of $200 in cash and $20 in Jazz stock. That is a sizeable premium on GW’s closing share price of around $147 …

Jazz agrees $7.2bn deal to buy cannabis meds pathfinder GW Pharma Read More »

Jazz to Acquire GW Pharmaceuticals for $7.2B

Shots: Jazz to acquire GW Pharmaceuticals for $220/ GW ADS, out of which $200 in cash and $20 in Jazz ordinary shares, making a total deal value $7.2B with a 50% premium over a GW’s closing stock price on Feb 2, 2021. The transaction expected to close in Q2’21 The acquisition will expand Jazz’ neuroscience …

Jazz to Acquire GW Pharmaceuticals for $7.2B Read More »

Carlyle Group, Brighton Park Capital Invest $200M in Indian Health Tech Provider Indegene to Fuel Global Expansion

What You Should Know: – The Carlyle Group and Brighton Park Capital invests $200M in Bangalore, India-based Indegene to accelerate company’s global expansion and consolidate its industry-leading position in healthtech solutions. – Founded in 1998 by five first-generation entrepreneurs, Indegene has emerged as the leading digital transformation partner to the global life sciences industry. With …

Carlyle Group, Brighton Park Capital Invest $200M in Indian Health Tech Provider Indegene to Fuel Global Expansion Read More »

Horizon Therapeutics to Acquire Viela Bio for ~ $3.05B

Shots: Horizon to acquire Viela Bio for $53/ share, representing an equity value of $3.05B with a 53% premium over a closing price to Viela’s on Jan 29, 2020. Additionally, AstraZeneca to divest its 26.7% ownership in Viela Bio in an exchange of ~$760 – $780M The transaction expected to close in Q1’21. The acquisition …

Horizon Therapeutics to Acquire Viela Bio for ~ $3.05B Read More »

Grant Avenue Capital Makes First Transaction in Buy-and-Build Home Health Play

Grant Avenue Capital recently acquired Salt Lake City-based Valeo Home Health & Hospice from Eduro Healthcare, an operator of skilled nursing facilities. The financial terms of the deal were not disclosed. New York-based Grant Avenue Capital is a middle-market private equity firm focused on health care. Founded in 2011, Valeo Home Health & Hospice has …

Grant Avenue Capital Makes First Transaction in Buy-and-Build Home Health Play Read More »

Ervaxx and Cardiff University Collaborate to Develop Novel T-cell and T-cell Receptor-based Immunotherapeutics Targeting Dark Antigens

Shots: Cardiff University will receive milestone payments that advance from the discovery collaboration into clinical development and royalty payments on sales of any products that reach the market. Ervaxx will fund this program Ervaxx gains an exclusive license to Cardiff University patents claiming T cells and TCRs reactive to cancer-specific antigens and has the right …

Ervaxx and Cardiff University Collaborate to Develop Novel T-cell and T-cell Receptor-based Immunotherapeutics Targeting Dark Antigens Read More »

Boston Scientific to Acquire Preventice for ~$1.2B

Shots: Boston Scientific to acquire Preventice for ~$1.2B including $925M as up front, up to an additional $300M as commercial milestones. However, Boston Scientific has built up a 22% stake in Preventice, which is expected to lower up front to $720M upfront & $230 million in milestone respectively The acquisition is expected to be close …

Boston Scientific to Acquire Preventice for ~$1.2B Read More »

Home Health Transaction Numbers Continue to Climb

Last fall, the home health M&A winds started to shift, with some industry insiders even predicting a record number of transactions to soon follow. New data suggests that point has arrived. Most had gone into 2020 believing that the Patient-Driven Groupings Model (PDGM) would jump start a period of “historic” M&A activity, but that ultimately …

Home Health Transaction Numbers Continue to Climb Read More »

Haemonetics to Acquire Cardiva Medical for ~$510M

Shots: Cardiva to receive $475M up front and up to an additional ~$35M in contingent consideration based on sales growth. The transaction is expected to be completed in Q1’21 The acquisition expands Haemonetics’ blood transfusion and loss management offerings and enhance its penetration into the large and growing interventional cardiology and electrophysiology markets Cardiva’s portfolio …

Haemonetics to Acquire Cardiva Medical for ~$510M Read More »

Thermo Fisher to Acquire Mesa Biotech for $450M

Shots: Thermo Fisher acquires Mesa Biotech for $450M in cash. Mesa Biotech will receive an additional ~$100M in cash on the completion of milestones while the transaction is expected to be completed in Q1’21 Mesa has developed & commercialized a PCR-based rapid POC testing platform for detecting infectious diseases. Messa’s technology inflates the availability of …

Thermo Fisher to Acquire Mesa Biotech for $450M Read More »

The Pennant Group Acquires Arizona Home Health Provider; Caring People Lands Multiple Home Care Companies

Pennant kicks off 2021 M&A activity The Pennant Group Inc. (Nasdaq: PNTG) has kicked off its 2021 M&A push. The Eagle, Idaho-based post-acute care provider announced Tuesday it has acquired Sacred Heart Home Health Care, which provides home health services in Phoenix and Tucson, Arizona. The acquisition was effective Jan. 16, 2021. “This strategic, off-market …

The Pennant Group Acquires Arizona Home Health Provider; Caring People Lands Multiple Home Care Companies Read More »

Tech-Enabled PBO RxBenefits Reaches $1.1B Valuation After Recapitalization

What You Should Know: – Private equity firm Advent International announced that it has completed a recapitalization of RxBenefits, the employee benefits industry’s first and only technology-enabled pharmacy benefits optimizer (PBO). – The transaction values RxBenefits at approximately $1.1 billion. Advent International (“Advent”), one of the largest and most experienced global private equity investors, today announced …

Tech-Enabled PBO RxBenefits Reaches $1.1B Valuation After Recapitalization Read More »

Philips to Acquire Capsule Technologies for ~$635M

Shots: Philips to acquire Capsule technologies for $635M in cash. The transaction is expected to be completed in H1’21 with the addition of ~300 employees of Capsule in Philips’ Connected Care segment The acquisition will expand Philips’ patient care management offering. The acquisition complements Philips’ strategy to transform the delivery of healthcare along the health …

Philips to Acquire Capsule Technologies for ~$635M Read More »

Traditions Health Acquires 4 Agencies; Help at Home Buys Adaptive

Traditions adds to post-acute care platform Traditions Health is adding to its growing post-acute care business. The College Station, Texas-based home health and hospice provider announced a handful of new acquisitions at the start of January. Financial terms of the transactions were not disclosed. In Oklahoma, Traditions acquired two home health agencies: Traditions Home Care …

Traditions Health Acquires 4 Agencies; Help at Home Buys Adaptive Read More »

W20 acquires data technology firms Swoop and IPM.ai

W20 has begun 2021 by buying data technology firms Swoop and IPM.ai, adding to its rapidly growing list of acquisitions. Representing the ninth acquisition for W2O in just over a year, the company said the acquisitions show its commitment to technology and the role it will play in the future of healthcare. As part of …

W20 acquires data technology firms Swoop and IPM.ai Read More »

Itamar buys Spry to add wearable to its sleep apnoea detectors

Israeli company Itamar Medical has agreed to acquire Spry Health, aiming to use the US company’s wearable technology to develop a watch-like remote monitor for sleep apnoea, a potentially life-threatening condition. Itamar already markets a sensing device called WatchPAT that attaches to the finger during sleep, measuring vital signs like heart and breathing rate, oxygen …

Itamar buys Spry to add wearable to its sleep apnoea detectors Read More »

European telehealth firm HealthHero buys MyClinic.ie

European telehealth firm HealthHero has bought MyClinic.ie, a rival based in the Republic of Ireland. Already a major telehealth player in Europe, HealthHero’s services cover 20 million people and 1,000 businesses across Europe. The acquisition means HealthHero has a direct-to-consumer offer in Ireland, where it was previously providing services through insurance companies and through businesses …

European telehealth firm HealthHero buys MyClinic.ie Read More »

59% of Health Care CFOs See Home Care as Key Investment Area

The majority of health care financial leaders view home care as a key area of investment. That’s according to a recent survey from BDO, a Chicago-based accounting, tax, financial advisory and consulting organization. Released Monday, the survey includes the responses of 100 CFOs at U.S. health care organizations, including home health providers, with revenues ranging …

59% of Health Care CFOs See Home Care as Key Investment Area Read More »

Sanofi buys UK’s Kymab and inflammatory disease hopeful for $1.45bn

Sanofi is to acquire UK biotech Kymab in a deal worth up to $1.45 billion as the big French pharma seeks to add to its pipeline of drugs that treat inflammatory diseases and cancer. Cambridge-based Kymab is one of several rising stars on the UK biotech scene, with technology that uses transgenic mice to develop …

Sanofi buys UK’s Kymab and inflammatory disease hopeful for $1.45bn Read More »

Bioclinica boosts digital trial credentials with Saliency buy

With the ink barely dry on its last merger agreement, clinical trial and imaging specialist Bioclinica is on an expansive drive once again, buying digital clinical trial specialist Saliency. Silicon Valley-based Saliency adds an artificial intelligence (AI) powered software platform that speeds up analysis of medical images and is used to support trials of pharmaceuticals …

Bioclinica boosts digital trial credentials with Saliency buy Read More »

PerkinElmer to Acquire Oxford Immunotec for ~$591M

Shots: PerkinElmer to acquire Oxford Immunotec for $22/ share with a premium of ~28.3% to the closing price/ share of $17.15 on Jan 5, 2021, making a total deal value $591M. The transaction is expected to be completed in H1’21 The acquisition allows the PerkinElmer to strengthen its portfolio of advanced infectious disease testing solutions …

PerkinElmer to Acquire Oxford Immunotec for ~$591M Read More »

Angelini and Arvelle create neurology player with $960m merger

There’s a new player in the neurology and mental health drugs market after Italy’s Angelini Pharma merged with Switzerland’s Arvelle Therapeutics in a deal worth up to $960 million based around the anti-seizure drug cenobamate. Angelini is an international pharma company that is part of the privately-owned Italian Angelini Group, while Arvelle is focused on …

Angelini and Arvelle create neurology player with $960m merger Read More »

Hologic to Acquire Biotheranostics for ~$230M

Shots: Hologic acquires Biotheranostics to speed up its entry in the oncology market. The transaction is expected to be completed in Feb’2021 The acquisition will provide Hologic access to Biotheranostics’ CLIA lab and will aid in accelerating market development for novel tests The acquisition allows Hologic to leverage commercial capabilities and expertise in molecular diagnostics …

Hologic to Acquire Biotheranostics for ~$230M Read More »

Merck KGaA Acquires AmpTec to Strengthen its mRNA Capabilities for Vaccines, Treatments and Diagnostics

Shots: The acquisition will integrate AmpTec’s PCR-based mRNA technology with Merck’s expertise in lipids manufacturing, providing combine offering across mRNA value chain The deal will expand Merck’s capabilities to develop & manufacture mRNA for use in vaccines, treatments, and diagnostics applicable in COVID-19 and many other diseases. Additionally, AmpTech’s diagnostic business focusing on customized long …

Merck KGaA Acquires AmpTec to Strengthen its mRNA Capabilities for Vaccines, Treatments and Diagnostics Read More »

Stryker Acquires OrthoSensor and its Knee Surgery Sensor Technology

Shots: Stryker acquires OrthoSensor and its Verasense intraoperative sensor tech, enhancing the ortho giant’s Mako robots The acquisition allows Stryker to empower surgeons with comprehensive data-driven solutions. The sensor tech will boost Mako surgical robotics systems, enhancing workflow through one complete data-driven feedback mechanism Moreover, OrthoSensor’s MotionSense remote patient monitoring wearables and mobile application combined …

Stryker Acquires OrthoSensor and its Knee Surgery Sensor Technology Read More »

LHC Group Finalizes Three Acquisitions; A-1 Preferred Sources Buys On The Mark Services

LHC Group finalizes hospice, palliative care purchases LHC Group Inc. (Nasdaq: LHCG) has finalized acquisition agreements in Arizona and Oklahoma. By doing so, the Lafayette, Louisiana-based home health, hospice and personal care services giant expands its scope of services in the Phoenix area while entering the Oklahoma hospice market for the first time. Specifically, LHC …

LHC Group Finalizes Three Acquisitions; A-1 Preferred Sources Buys On The Mark Services Read More »

Hologic to Acquire Somatex for ~$64 M

Shots: Hologic acquired Somatex Medical Technologies for ~$64M. The acquisition of Somatex’s differentiated products will enable Hologic to strengthen & expand its breast marker portfolio The acquisition allows the company to expand its biopsy portfolio with the improvement in the biopsy experience for their patients. The acquisition provides Hologic additional expertise and capabilities to continue …

Hologic to Acquire Somatex for ~$64 M Read More »

WellSky Completes $1.35B Purchase of CarePort Health

WellSky announced Thursday that it has completed its acquisition of care coordination software company CarePort Health. Under terms of the deal — first announced in October — WellSky purchased CarePort from Allscripts Healthcare Solutions (Nasdaq: MDRX) for a price tag of $1.35 billion. Allscripts is a health care information technology provider. CarePort’s platform helps health …

WellSky Completes $1.35B Purchase of CarePort Health Read More »

Servier beefs up in cancer, buying Agios’ oncology business for $1.8bn

French pharmaceutical company Servier has swooped on Agios Pharma’s marketed and experimental cancer drugs, buying the entire franchise in a deal that leaves the US biopharma focused on genetic disorders. It’s a major change of direction for Boston-based Agios, which has been concentrating on the oncology market since its inception in 2008, bringing the Bristol …

Servier beefs up in cancer, buying Agios’ oncology business for $1.8bn Read More »

AccentCare, Seasons Finalize Merger Aimed at Streamlining Patient Care

AccentCare and Seasons Hospice & Palliative Care have cleared all regulatory hurdles and officially merged, the post-acute care providers announced Tuesday. The Dallas, Texas-based AccentCare is ranked as the fifth-largest home health provider in the nation in terms of overall market share, according to LexisNexis statistics. Similarly, the Rosemont, Illinois-based Seasons is listed as the …

AccentCare, Seasons Finalize Merger Aimed at Streamlining Patient Care Read More »

Servier to Acquire Agios’ Oncology Business for ~$2B

Shots: Agios to receive ~$1.8B upfront in cash & ~$200M as regulatory milestones for Vorasidenib along with 5% royalties on sales of Tibsovo in the US from transaction close through the loss of exclusivity and 15% royalties on sales of vorasidenib in the US from first commercial sale through the loss of exclusivity The acquisition …

Servier to Acquire Agios’ Oncology Business for ~$2B Read More »

Blank-Check Company Deerfield to Combine CareMax, IMC Medical Group in $614M Play

The health care SPAC boom continues. On Friday, Deerfield Healthcare Technology Acquisitions Corp. (Nasdaq: DFHT) announced it is acquiring CareMax Medical Group and IMC Medical Group Holdings for $364 million and $250 million, respectively. The New York-based Deerfield — a special purpose acquisition company — says it plans on merging the two senior care organizations …

Blank-Check Company Deerfield to Combine CareMax, IMC Medical Group in $614M Play Read More »

The top 5 pharma M&A deals of 2020

2020’s M&A activity hasn’t quite reached the heights of last year’s, where two pharma mega-mergers – BMS’ buyout of Celegne and AbbVie’s acquisition of Allergan – accounted for almost 40% of total M&A deal values. That said, there were still some interesting moves indicating new directions of travel for big pharma players – with most …

The top 5 pharma M&A deals of 2020 Read More »

Philips to Acquire BioTelemetry for ~$2.8B

Shots: Philips to acquire all outstanding shares of BioTelemetry and its wearable heart-tracking devices for $72/ share in cash with a 16.5 % premium to a closing price of BioTelemetry on Dec 17, 2020, making a total value ~$2.8B. The transaction is expected to be completed in Q1’21 The acquisition complements Philips’ cardiac care portfolio …

Philips to Acquire BioTelemetry for ~$2.8B Read More »

Backed by Harpeth Capital, Industry Veteran Launches HomeFirst Home Healthcare

Backed by investment bank Harpeth Capital, a home-based care veteran recently threw his weight behind a new home health venture. The new company is called HomeFirst Home Healthcare, led by James Happ, who serves as president and CEO. If Happ’s name sounds familiar, it’s because he spent some time at the leadership level of SunCrest …

Backed by Harpeth Capital, Industry Veteran Launches HomeFirst Home Healthcare Read More »

Novartis to Acquire Cadent Therapeutics for ~$770M

Shots: Novartis to acquire all outstanding shares of Cadent for a total value of ~$770M. Cadent to receive $210M up front and is eligible for ~$560M as milestones. The transaction is expected to be close in Q1’21 Novartis gains full rights to Cadent’s NMDAr program which consist of two clinical programs: CAD-9303 and MIJ-821, an …

Novartis to Acquire Cadent Therapeutics for ~$770M Read More »

Novartis buys neurology biotech Cadent for up to $770m

Novartis is to buy neuroscience drugs firm Cadent Therapeutics in a deal worth up to $770 million. The big Swiss pharma already has a presence in neurology with its multiple sclerosis drug Gilenya (fingolimod) and the more recently approved Aimovig (erenumab). With the acquisition of Cambridge, Massachusetts-based Cadent, Novartis gains rights to a portfolio of …

Novartis buys neurology biotech Cadent for up to $770m Read More »

VC Insider Chris Booker: There’s Definitely More Capital Moving Toward Home-Based Care

The degree to which venture capitalists were interested in at-home care may have been overplayed at one point. But that’s becoming less and less the case. That’s according to Chris Booker, a partner at the Nashville, Tennessee-based venture capital firm Frist Cressey Ventures, which has itself frequently invested in the at-home care space. “From a …

VC Insider Chris Booker: There’s Definitely More Capital Moving Toward Home-Based Care Read More »

Lilly pays up to $1.04bn for neurology gene therapy biotech Prevail

Eli Lilly has acquired Prevail, a biotech focusing on gene therapies for neurodegenerative diseases including Parkinson’s, in a deal potentially worth more than $1 billion. The big US pharma is to pay up to $1.04 billion to buy Prevail, paying $22.5 per share up front plus a $4 contingent value right (CVR) to sweeten the …

Lilly pays up to $1.04bn for neurology gene therapy biotech Prevail Read More »

Lilly to Acquire Prevail Therapeutics for ~$1.04B

Shots: Lilly to acquire Prevail for $22.50/ share in cash (~ $880M) payable at closing plus one non-tradable CVR worth up to $4.00/ share in cash (~160M), making a total of $26.50/share in cash (~$1.040B). The transaction is expected to be close in Q1’21 The CVR is payable upon the first regulatory approval of a …

Lilly to Acquire Prevail Therapeutics for ~$1.04B Read More »

Brookdale Senior Living Reportedly Exploring Sale of Home Health and Hospice Businesses

After falling short on Q3 projections and seeing revenue dip year over year, Brookdale Senior Living (NYSE: BKD) is reportedly considering divesting its home health and hospice segments. COVID-19’s impact on the company has created financial pressures that it hopes to mitigate, PEHub Reported Monday. Those pressures could feasibly be made up, in part, through …

Brookdale Senior Living Reportedly Exploring Sale of Home Health and Hospice Businesses Read More »

AstraZeneca to Acquire Alexion for $39B

Shots: Alexion to receive $60M in cash and 2.1243 ADSs (each ADS represents ½ ordinary share of AstraZeneca) for each Alexion share. The deal values Alexion at $175/ share with a 45% premium to the closing price on Dec 11, 2020 Alexion will own ~15% of the combined company. The acquisition will bolster AstraZeneca’s footprints …

AstraZeneca to Acquire Alexion for $39B Read More »

The Care Team Expands Footprint with InTeliCare Purchase; CareFinders Buys Union Home Care

The Care Team acquires InTeliCare Private equity-backed The Care Team has acquired InTeliCare Home Health & Hospice. The financial terms of the deal were not disclosed. Farmington Hills, Michigan-based The Care Team is a home-based care provider that delivers a variety of services including nursing, therapy and hospice services across central and eastern Michigan. The …

The Care Team Expands Footprint with InTeliCare Purchase; CareFinders Buys Union Home Care Read More »

Alexion finally has a buyer – and it’s AstraZeneca with $39bn on the table

Alexion has routinely featured among lists of top biopharma takeover prospects in the last couple of years, and that was a good call – AstraZeneca has just swooped in with $39 billion cash-and-stock takeover offer. The deal – the largest in the pharma sector since the start of the pandemic – bolsters AZ’s immunology franchise …

Alexion finally has a buyer – and it’s AstraZeneca with $39bn on the table Read More »

Alexion finally has a buyer – and it’s AstraZeneca with $39bn on the table

Alexion has routinely featured among lists of top biopharma takeover prospects in the last couple of years, and that was a good call – AstraZeneca has just swooped in with $39 billion cash-and-stock takeover offer. The deal – the largest in the pharma sector since the start of the pandemic – bolsters AZ’s immunology franchise …

Alexion finally has a buyer – and it’s AstraZeneca with $39bn on the table Read More »

ERT to merge with clinical imaging firm Bioclinica

ERT, a clinical services firm with expertise in digital technology is to merge with clinical imaging firm Bioclinica. The companies said that the combination will strengthen their offering to pharmaceutical and biotech companies. The transaction will integrate Bioclinica’s expertise in imaging with ERT’s expertise in electronic clinical outcome assessment, cardiac safety, respiratory and wearables. The …

ERT to merge with clinical imaging firm Bioclinica Read More »

Gilead to Acquire MYR for ~$1.4B

Shots: Gilead to acquire MYR for ~$1.4B in the all-cash transaction along with ~$364.73M as a milestone upon the US FDA’s approval of Hepcludex (bulevirtide) The acquisition will provide Gilead with Hepcludex which has received EMA’s conditional approval for chronic HDV infection in adults with compensated liver disease in Jul’2020. MYR anticipates the submission for …

Gilead to Acquire MYR for ~$1.4B Read More »

Boehringer Ingelheim to Acquires NBE-Therapeutics ~ $1.5B

Shots: Boehringer Ingelheim to acquire all shares of NBE-Therapeutics for ~$1.434B which include contingent clinical and regulatory milestones. The transaction is expected to be closed in Q1’21 The acquisition will add NBE-Therapeutics’ ROR1-directed ADCs including NBE-002 which is currently in P-I studies for TNBC and other solid tumors NBE-Therapeutics’ iADC platform will add exceptional tumor-targeting …

Boehringer Ingelheim to Acquires NBE-Therapeutics ~ $1.5B Read More »

Boehringer buys NBE for €1.18bn, adding cancer ADC expertise

Boehringer Ingelheim has expanded its oncology focus for the second time this week by buying Swiss biotech NBE-Therapeutics, adding an antibody-drug conjugate (ADC) platform led by a drug for a hard-to-treat form of breast cancer. The German pharma group is paying €1.18 billion ($1.43bn) for all the shares in privately-held NBE, based in Basel, and …

Boehringer buys NBE for €1.18bn, adding cancer ADC expertise Read More »

Boehringer Ingelheim to Acquires Labor Dr. Merk & Kollegen for Boosting its Next Generation Cancer Immunology Program

Shots: The acquisition will enable Boehringer Ingelheim to expand and accelerate its comprehensive program for the development of ATMP-based immuno-oncology therapies including the VSV with modified GP platform and cancer vaccines platforms The addition of Labor Dr. Merk & Kollegen’s site will enable Boehringer Ingelheim to further strengthen its oncolytic virus and cancer vaccine development …

Boehringer Ingelheim to Acquires Labor Dr. Merk & Kollegen for Boosting its Next Generation Cancer Immunology Program Read More »